###begin article-title 0
###xml 3 7 3 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf</sup>
p19 Arf Suppresses Growth, Progression, and Metastasis of Hras-Driven Carcinomas through p53-Dependent and -Independent Pathways
###end article-title 0
###begin article-title 1
Deterministic Tumor Evolution
###end article-title 1
###begin p 2
###xml 40 43 40 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ras</italic>
###xml 69 72 69 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 254 257 254 257 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 348 351 348 351 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 345 351 345 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>Arf</sup></italic>
###xml 367 370 367 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 448 452 448 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hras</italic>
###xml 610 613 610 613 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 607 614 607 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>Arf</sup>-</italic>
###xml 645 648 645 648 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 814 817 814 817 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 810 818 810 818 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19&#8202;<sup>Arf</sup>-</italic>
###xml 823 826 823 826 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 852 855 852 855 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 954 957 954 957 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 1082 1086 1082 1086 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf</sup>
###xml 1079 1086 1079 1086 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf</sup></italic>
###xml 1166 1170 1166 1170 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf</sup>
###xml 1163 1170 1163 1170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf</sup></italic>
###xml 1222 1225 1222 1225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 1306 1311 1306 1311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hras,</italic>
###xml 1330 1333 1330 1333 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 299 304 <span type="species:ncbi:10090">mouse</span>
###xml 381 385 <span type="species:ncbi:10090">mice</span>
###xml 556 560 <span type="species:ncbi:10090">mice</span>
###xml 624 628 <span type="species:ncbi:10090">mice</span>
###xml 659 663 <span type="species:ncbi:10090">mice</span>
###xml 837 841 <span type="species:ncbi:10090">mice</span>
###xml 1092 1096 <span type="species:ncbi:10090">mice</span>
Ectopic expression of oncogenes such as Ras induces expression of p19Arf, which, in turn, activates p53 and growth arrest. Here, we used a multistage model of squamous cell carcinoma development to investigate the functional interactions between Ras, p19Arf, and p53 during tumor progression in the mouse. Skin tumors were induced in wild-type, p19Arf-deficient, and p53-deficient mice using the DMBA/TPA two-step protocol. Activating mutations in Hras were detected in all papillomas and carcinomas examined, regardless of genotype. Relative to wild-type mice, the growth rate of papillomas was greater in p19Arf-deficient mice, and reduced in p53-deficient mice. Malignant conversion of papillomas to squamous cell carcinomas, as well as metastasis to lymph nodes and lungs, was markedly accelerated in both p19 Arf- and p53-deficient mice. Thus, p19Arf inhibits the growth rate of tumors in a p53-independent manner. Through its regulation of p53, p19Arf also suppresses malignant conversion and metastasis. p53 expression was upregulated in papillomas from wild-type but not p19 Arf-null mice, and p53 mutations were more frequently seen in wild-type than in p19 Arf-null carcinomas. This indicates that selection for p53 mutations is a direct result of signaling from the initiating oncogenic lesion, Hras, acting through p19Arf.
###end p 2
###begin p 3
A squamous cell carcinoma model shows Ras mutation not only initiates tumor development but, through Arf and p53, directly influences the subsequent evolutionary trajectory of the tumors
###end p 3
###begin title 4
Introduction
###end title 4
###begin p 5
###xml 239 264 239 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Hanahan1">Hanahan and Weinberg 2000</xref>
###xml 413 428 413 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-DiGiovanni1">DiGiovanni 1992</xref>
###xml 1013 1017 1013 1017 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ras,</italic>
###xml 1049 1052 1049 1052 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 1045 1053 1045 1053 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19&#8202;<sup>Arf</sup>,</italic>
###xml 1058 1062 1058 1062 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53,</italic>
###xml 712 717 <span type="species:ncbi:9606">human</span>
Tumor development and metastasis is a multistep process of somatic cell evolution that includes uncontrolled proliferation, impaired apoptosis, loss of differentiation, immortalization, neovascularization, invasion, and metastatic spread (Hanahan and Weinberg 2000). This evolutionary transformation can be operationally divided into distinct stages, including initiation, promotion, progression, and metastasis (DiGiovanni 1992). Mutations in both oncogenes and tumor suppressor genes are found in end-stage tumors, implying their causal role in tumor development. However, the association of mutations in specific genes with specific phenotypic states during tumor progression is poorly characterized for most human solid tumors. It is also largely unknown whether each mutation is an independent event or whether there is a preferred sequence or combination of mutations that is favored. The purpose of this study is to investigate the functional interactions between the mutational activation of the oncogene Ras, and two tumor suppressors, p19 Arf, and p53, using a multistage epithelial tumor model.
###end p 5
###begin p 6
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ras</italic>
###xml 165 176 165 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hras, Kras,</italic>
###xml 180 184 180 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nras</italic>
###xml 186 194 186 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Bos1">Bos 1989</xref>
###xml 228 231 228 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ras</italic>
###xml 502 522 502 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Campbell1">Campbell et al. 1998</xref>
###xml 604 624 604 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Pozzatti1">Pozzatti et al. 1986</xref>
###xml 626 642 626 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Webb1">Webb et al. 1998</xref>
###xml 644 664 644 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Varghese1">Varghese et al. 2002</xref>
###xml 54 59 <span type="species:ncbi:9606">human</span>
Ras is among the most frequently mutated oncogenes in human cancer, with approximately 30% of tumors carrying an activating mutation in one of three family members, Hras, Kras, or Nras (Bos 1989). Cancer-associated mutations in Ras result in constitutively active Ras protein. Ras is a nodal signaling molecule that regulates multiple signaling pathways, leading to profound changes in cellular proliferation, apoptosis, differentiation, senescence, cytoskeletal organization, adhesion, and migration (Campbell et al. 1998). Ras has also been shown to induce invasiveness and metastasis of cancer cells (Pozzatti et al. 1986; Webb et al. 1998; Varghese et al. 2002). These pleiotropic effects suggest Ras may influence multiple steps in tumor progression.
###end p 6
###begin p 7
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 122 143 122 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Hollstein1">Hollstein et al. 1994</xref>
###xml 372 390 372 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Ko1">Ko and Prives 1996</xref>
###xml 392 415 392 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Giaccia1">Giaccia and Kastan 1998</xref>
###xml 588 610 588 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Siognov1">Siognov and Haupt 1999</xref>
###xml 612 631 612 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Vousden1">Vousden and Lu 2002</xref>
###xml 60 65 <span type="species:ncbi:9606">human</span>
p53 is the most frequently mutated tumor suppressor gene in human cancer, with more than 50% of tumors showing mutations (Hollstein et al. 1994). p53 is a nodal signaling protein that coordinates the cellular response to different types of stress, including oncogene activation, DNA damage, abnormal cell adhesion, altered ribonucleotide pools, hypoxia, and redox stress (Ko and Prives 1996; Giaccia and Kastan 1998). These stress stimuli are thought to activate p53 by inducing posttranslational modifications that stabilize p53 and enhance its ability to act as a transcription factor (Siognov and Haupt 1999; Vousden and Lu 2002). Loss of p53 function leads to loss of cell cycle checkpoints, impaired apoptosis, genomic instability, and tumor progression. However, a major unresolved issue is, of the many signals that have been shown to activate p53 using a variety of model systems, which one regulates p53 during autochthonous tumor progression.
###end p 7
###begin p 8
###xml 107 110 107 110 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 140 143 140 143 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 148 151 148 151 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 163 180 163 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Stott1">Stott et al. 1998</xref>
###xml 203 208 203 208 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ink4a</sup>
###xml 212 216 212 216 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf</sup>
###xml 200 216 200 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p16<sup>Ink4a</sup>/p19<sup>&#8202;Arf</sup></italic>
###xml 330 335 330 335 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ink4a</sup>
###xml 345 363 345 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Quelle1">Quelle et al. 1995</xref>
###xml 365 383 365 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Kamijo1">Kamijo et al. 1997</xref>
###xml 419 424 419 424 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ink4a</sup>
###xml 428 432 428 432 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf</sup>
###xml 416 432 416 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p16<sup>Ink4a</sup>/p19<sup>&#8202;Arf</sup></italic>
###xml 501 521 501 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Ruas1">Ruas and Peters 1998</xref>
###xml 527 530 527 530 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 619 622 619 622 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 676 694 676 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Kamijo1">Kamijo et al. 1997</xref>
###xml 770 781 770 781 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ras, c-Myc,</italic>
###xml 786 789 786 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E1A</italic>
###xml 901 920 901 920 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Lowe1">Lowe and Ruley 1993</xref>
###xml 922 945 922 945 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Hermeking1">Hermeking and Eick 1994</xref>
###xml 947 966 947 966 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Serrano1">Serrano et al. 1997</xref>
###xml 1097 1100 1097 1100 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 1210 1213 1210 1213 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 1278 1296 1278 1296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Kamijo1">Kamijo et al. 1997</xref>
###xml 1298 1315 1298 1315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Stott1">Stott et al. 1998</xref>
###xml 1335 1338 1335 1338 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 1477 1494 1477 1494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Zindy1">Zindy et al. 1998</xref>
###xml 1496 1520 1496 1520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-de1">de Stanchina et al. 1998</xref>
###xml 1522 1541 1522 1541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Palmero1">Palmero et al. 1998</xref>
###xml 1543 1560 1543 1560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Lin1">Lin and Lowe 2001</xref>
###xml 1562 1582 1562 1582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Ferbeyre1">Ferbeyre et al. 2002</xref>
###xml 1635 1638 1635 1638 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 1756 1759 1755 1758 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 1812 1815 1810 1813 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 1856 1875 1854 1873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Eischen1">Eischen et al. 1999</xref>
###xml 1877 1896 1875 1894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Schmitt1">Schmitt et al. 1999</xref>
###xml 1902 1905 1900 1903 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 2071 2088 2069 2086 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Haupt1">Haupt et al. 1997</xref>
###xml 2090 2110 2088 2108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Kubbutat1">Kubbutat et al. 1997</xref>
###xml 2252 2268 2250 2266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Roth1">Roth et al. 1998</xref>
###xml 2270 2291 2268 2289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Honda1">Honda and Yasuda 1999</xref>
###xml 2297 2300 2295 2298 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 2436 2457 2434 2455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Pomerantz1">Pomerantz et al. 1998</xref>
###xml 2459 2478 2457 2476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Tao1">Tao and Levine 1999</xref>
###xml 2480 2497 2478 2495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Weber1">Weber et al. 1999</xref>
###xml 2499 2519 2497 2517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Zhang1">Zhang and Xiong 1999</xref>
###xml 155 161 <span type="species:ncbi:9606">humans</span>
###xml 487 492 <span type="species:ncbi:9606">human</span>
###xml 603 607 <span type="species:ncbi:10090">mice</span>
###xml 1714 1717 <span type="species:ncbi:8790">Emu</span>
###xml 1722 1726 <span type="species:ncbi:10090">mice</span>
###xml 1781 1784 <span type="species:ncbi:8790">Emu</span>
###xml 1789 1793 <span type="species:ncbi:10090">mice</span>
A mechanistic connection between Ras signaling and activation of p53 that involves the tumor suppressor p19Arf was recently established. p19Arf (p14Arf in humans; Stott et al. 1998) is encoded by the p16Ink4a/p19 Arf locus, but because it is transcribed in an alternative reading frame, the protein product is unrelated to the p16Ink4a protein (Quelle et al. 1995; Kamijo et al. 1997). Deletions or mutations at the p16Ink4a/p19 Arf locus are frequently (more than 50% of cases) seen in human tumors (Ruas and Peters 1998). p19Arf was established as a bona fide tumor suppressor in studies showing that mice lacking p19Arf are highly susceptible to spontaneous tumorigenesis (Kamijo et al. 1997). In vitro studies had shown that enforced expression of oncogenes such as Ras, c-Myc, and E1A activated p53 and induced growth arrest, senescence, or apoptosis depending on the cell type or oncogene used (Lowe and Ruley 1993; Hermeking and Eick 1994; Serrano et al. 1997). These cellular responses were impaired in cells lacking p53, indicating that functional p53 was required. The involvement of p19Arf was first suggested by experiments showing that enforced expression of Ras, Myc, and E1A in cells induced p19Arf, leading to G1 and G2 cell cycle arrest that was p53-dependent (Kamijo et al. 1997; Stott et al. 1998). Cells lacking p19Arf showed impaired p53 induction in response to these oncogenes, and, like p53-deficient cells, escaped growth arrest and were immortalized (Zindy et al. 1998; de Stanchina et al. 1998; Palmero et al. 1998; Lin and Lowe 2001; Ferbeyre et al. 2002). In vivo evidence linking oncogene signaling to p19Arf and p53 was obtained in a lymphoma model. B-cell lymphomas from transgenic Emu-myc mice also show a dependence on p19Arf to activate p53, and Emu-myc mice lacking either p19Arf or p53 developed lymphomas much faster (Eischen et al. 1999; Schmitt et al. 1999). p19Arf regulates p53 through mutual binding to the p53 regulator Mdm2. The levels of p53 in cells are normally kept low because of feedback regulation by the Mdm2 protein (Haupt et al. 1997; Kubbutat et al. 1997). Mdm2 binds to p53 and targets it for degradation by nuclear to cytoplasmic shuttling and through the E3 ubiquitin ligase activity of Mdm2 (Roth et al. 1998; Honda and Yasuda 1999). p19Arf sequesters Mdm2 from p53 and inhibits the ubiquitin ligase activity of Mdm2, resulting in increased stability and accumulation of p53 (Pomerantz et al. 1998; Tao and Levine 1999; Weber et al. 1999; Zhang and Xiong 1999).
###end p 8
###begin p 9
###xml 29 32 29 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 186 206 186 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Ferbeyre1">Ferbeyre et al. 2002</xref>
###xml 208 227 208 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Palmero1">Palmero et al. 1998</xref>
###xml 266 283 266 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Lin1">Lin and Lowe 2001</xref>
###xml 367 370 367 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ras</italic>
###xml 435 438 435 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ras</italic>
###xml 517 539 517 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Finney1">Finney and Bishop 1993</xref>
###xml 586 589 586 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ras</italic>
###xml 632 655 632 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Quintanilla1">Quintanilla et al. 1986</xref>
###xml 657 681 657 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Bremner1">Bremner and Balmain 1990</xref>
###xml 865 884 865 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Shields1">Shields et al. 2000</xref>
###xml 977 980 977 980 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 1020 1042 1020 1042 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Sherr1">Sherr and DePinho 2000</xref>
###xml 1044 1063 1044 1063 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Lowe2">Lowe and Sherr 2003</xref>
###xml 1194 1197 1194 1197 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 156 162 <span type="species:ncbi:10090">murine</span>
###xml 1302 1307 <span type="species:ncbi:9606">human</span>
The importance of the Ras-p19Arf-p53 pathway in growth arrest was established in culture systems involving the ectopic overexpression of mutant Ras in both murine embryonic fibroblasts (Ferbeyre et al. 2002; Palmero et al. 1998) and primary epidermal keratinocytes (Lin and Lowe 2001). Both in vitro and in vivo models have established that the gene dosage of mutant Ras is critical for its oncogenic function. A single copy of mutant Ras is insufficient to transform cells; at least two mutant alleles are required (Finney and Bishop 1993). Duplication or even amplification of mutant Ras alleles is frequently observed in tumors (Quintanilla et al. 1986; Bremner and Balmain 1990). Ras activates multiple signaling pathways, and quantitative differences in Ras activity can lead to activation of different signals and qualitatively different cellular phenotypes (Shields et al. 2000). Cell culture conditions can add additional stress signals that are known to impinge on p19Arf and p53, leading to cell cycle arrest (Sherr and DePinho 2000; Lowe and Sherr 2003), and cannot recapitulate the complex cellular ecology of tumor progression. Thus, to understand the interactions between Ras, p19Arf, and p53 that drive tumor progression, an autochthonous tumor model is required. Since more than 90% of human cancers are epithelial in origin, a carcinoma model system is favored.
###end p 9
###begin p 10
###xml 191 206 191 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-DiGiovanni1">DiGiovanni 1992</xref>
###xml 457 461 457 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hras</italic>
###xml 463 486 463 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Quintanilla1">Quintanilla et al. 1986</xref>
###xml 1007 1017 1007 1017 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Yuspa1">Yuspa 1994</xref>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 263 267 <span type="species:ncbi:10090">mice</span>
###xml 1039 1043 <span type="species:ncbi:10090">mice</span>
Mouse skin carcinogenesis is perhaps the best-characterized in vivo model of epithelial neoplasia and was instrumental in establishing the concepts of initiation, promotion, and progression (DiGiovanni 1992). The two-stage chemical protocol involves treatment of mice with a carcinogen, DMBA, followed by multiple applications of TPA. This treatment induces benign squamous cell papillomas, nearly 100% of which have sustained an AT mutation in codon 61 of Hras (Quintanilla et al. 1986). As this mutation results in constitutively active Ras protein, this protocol is ideal to study the biological consequence of Ras activation during the entire natural history of tumor progression. Papillomas consist of a series of folded epidermal or follicular hyperplasias that protrude from the skin surface. Papillomas have dysplastic characteristics including disturbed cell polarity, basal cell hyperplasia, disturbed maturational sequence, increased mitotic activity, and increased nuclear to cytoplasmic ratio (Yuspa 1994). In most strains of mice, progression of these benign papillomas to malignant squamous cell carcinomas (SCCs) is a rare and late event. SCCs are usually endophytic tumors that present as plaques with an ulcerated surface. These tumors break through the basement membrane and progressively invade the underlying dermis and subcutaneous tissues, and rarely, can metastasize to regional and distant sites. SCCs are characterized by a disorderly proliferation of epithelial cells with increased cellular atypia and abnormal mitotic figures, and are classified into four grades: well-differentiated, moderately differentiated, poorly differentiated, and spindle cell carcinoma. The unique advantage of this skin tumor model is the ability to directly observe and quantify these evolutionary stages.
###end p 10
###begin p 11
###xml 188 205 188 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Burns1">Burns et al. 1991</xref>
###xml 207 226 207 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Ruggeri1">Ruggeri et al. 1991</xref>
###xml 295 311 295 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Kemp1">Kemp et al. 1993</xref>
###xml 393 396 393 396 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 390 396 390 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>+/&#8722;</sup></italic>
###xml 454 457 454 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 242 246 <span type="species:ncbi:10090">mice</span>
###xml 397 401 <span type="species:ncbi:10090">mice</span>
Loss of p53 function is strongly associated with the benign to malignant transition of chemically induced SCCs. Mutations in p53 are seen more frequently in carcinomas than in papillomas (Burns et al. 1991; Ruggeri et al. 1991). p53 knockout mice show accelerated malignant progression of SCCs (Kemp et al. 1993). The strongest association of p53 with malignant progression was revealed in p53+/- mice, in which loss of the remaining wild-type allele of p53 was seen in carcinomas but not papillomas, indicating a strong selective pressure to completely inactivate p53 during this transition. Accelerated malignant progression seen in the absence of p53 was accompanied by extensive loss of differentiation and lymph node metastasis, indicating that p53 inhibits multiple steps involved in malignant tumor progression.
###end p 11
###begin p 12
###xml 67 70 67 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 224 227 224 227 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 318 321 318 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 344 348 344 348 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf</sup>
###xml 341 348 341 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf</sup></italic>
###xml 476 479 476 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 495 498 495 498 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 491 498 491 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19&#8202;<sup>Arf</sup></italic>
###xml 632 635 632 635 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 18 23 <span type="species:ncbi:10090">mouse</span>
###xml 327 331 <span type="species:ncbi:10090">mice</span>
###xml 485 489 <span type="species:ncbi:10090">mice</span>
###xml 504 508 <span type="species:ncbi:10090">mice</span>
Here, we used the mouse skin tumor model to examine the role of p19Arf in regulating the levels and tumor suppressor activity of p53. In addition, we addressed the biological and functional significance of alterations in p19Arf, p53, or both during tumor initiation, promotion, progression, and metastasis. Similar to p53-null mice, loss of p19 Arf resulted in increased malignant conversion, more aggressive tumors, and frequent and rapid metastasis. However, in contrast to p53-null mice, p19 Arf-null mice had greater tumor numbers and tumor growth rates, indicating additional, p53-independent tumor suppressor functions for p19Arf.
###end p 12
###begin title 13
Results
###end title 13
###begin title 14
###xml 42 45 42 45 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 56 60 <span type="species:ncbi:10090">Mice</span>
Increased Papilloma Number and Size in p19Arf-Deficient Mice
###end title 14
###begin p 15
###xml 60 63 60 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 87 106 87 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Eischen1">Eischen et al. 1999</xref>
###xml 108 126 108 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Kamijo2">Kamijo et al. 1999</xref>
###xml 128 147 128 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Schmitt1">Schmitt et al. 1999</xref>
###xml 149 166 149 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Lin1">Lin and Lowe 2001</xref>
###xml 250 253 250 253 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 306 313 306 313 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf+/+</sup>
###xml 303 313 303 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf+/+</sup></italic>
###xml 318 322 318 322 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf</sup>
###xml 315 322 315 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf</sup></italic>
###xml 322 325 322 325 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 334 339 334 339 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf&#8722;</sup>
###xml 331 339 331 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf&#8722;</sup></italic>
###xml 339 341 339 341 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">/&#8722;</sup>
###xml 453 474 453 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 565 572 565 572 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf+/&#8722;</sup>
###xml 562 572 562 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf+/&#8722;</sup></italic>
###xml 580 587 580 587 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf&#8722;/&#8722;</sup>
###xml 577 587 577 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf&#8722;/&#8722;</sup></italic>
###xml 680 688 680 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020242-g001">Figure 1</xref>
###xml 730 737 730 737 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf&#8722;/&#8722;</sup>
###xml 727 737 727 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf&#8722;/&#8722;</sup></italic>
###xml 804 805 804 805 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 822 829 822 829 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf+/&#8722;</sup>
###xml 819 829 819 829 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf+/&#8722;</sup></italic>
###xml 896 897 896 897 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1000 1007 1000 1007 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf&#8722;/&#8722;</sup>
###xml 997 1007 997 1007 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf&#8722;/&#8722;</sup></italic>
###xml 1015 1022 1015 1022 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf+/&#8722;</sup>
###xml 1012 1022 1012 1022 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf+/&#8722;</sup></italic>
###xml 1056 1064 1056 1064 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020242-g001">Figure 1</xref>
###xml 1187 1194 1187 1194 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf&#8722;/&#8722;</sup>
###xml 1184 1194 1184 1194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf&#8722;/&#8722;</sup></italic>
###xml 1276 1277 1276 1277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1308 1312 1308 1312 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf</sup>
###xml 1305 1312 1305 1312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf</sup></italic>
###xml 1439 1443 1439 1443 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf</sup>
###xml 1436 1443 1436 1443 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf</sup></italic>
###xml 1519 1523 1519 1523 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf</sup>
###xml 1516 1523 1516 1523 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf</sup></italic>
###xml 588 592 <span type="species:ncbi:10090">mice</span>
###xml 674 678 <span type="species:ncbi:10090">mice</span>
###xml 738 742 <span type="species:ncbi:10090">mice</span>
###xml 830 834 <span type="species:ncbi:10090">mice</span>
###xml 1023 1027 <span type="species:ncbi:10090">mice</span>
###xml 1050 1054 <span type="species:ncbi:10090">mice</span>
###xml 1195 1199 <span type="species:ncbi:10090">mice</span>
###xml 1270 1274 <span type="species:ncbi:10090">mice</span>
###xml 1323 1327 <span type="species:ncbi:10090">mice</span>
###xml 1400 1404 <span type="species:ncbi:10090">mice</span>
Both in vitro and in vivo studies have demonstrated that p19Arf is a tumor suppressor (Eischen et al. 1999; Kamijo et al. 1999; Schmitt et al. 1999; Lin and Lowe 2001). However, other than regulation of p53, little else is known about the role of p19Arf in tumor suppression. To address this, groups of p19 Arf+/+, p19 Arf+/-, and p19 Arf-/- littermates were treated with a single dose of DMBA followed by twice weekly application of TPA for 15 wk (see Materials and Methods). Papillomas began to appear in all three genotypes after 9 wk of promotion. By 20 wk, p19 Arf+/- and p19 Arf-/- mice showed a significant increase in papilloma number and size compared to wild-type mice (Figure 1A). Relative to wild-type littermates, p19 Arf-/- mice had an average of 2.97 more papillomas (95% CI (0.70, 5.24); p = 0.010) and p19 Arf+/- mice had an average of 2.60 more papillomas (95% CI (0.05, 5.14); p = 0.045) in weeks 18-30 after DMBA administration. Average papilloma size was also greater in both p19 Arf-/- and p19 Arf+/- mice compared to wild-type mice (Figure 1B). This effect was seen as early as 12 wk and increased through time so that by 28 wk, 33% (47/141) of papillomas from p19 Arf-/- mice were greater than 8 mm in diameter versus 14% (38/267) from wild-type mice (p < 0.0001). Papillomas from p19 Arf-deficient mice measured up to 16 mm in diameter while very few papillomas on wild-type mice measured more than 9 mm. Thus, p19 Arf deficiency resulted in faster growing papillomas, indicating a role for p19 Arf in regulating the early stages of benign tumor growth.
###end p 15
###begin p 16
###xml 13 17 13 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hras</italic>
###xml 78 101 78 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Quintanilla1">Quintanilla et al. 1986</xref>
###xml 103 119 103 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Kemp1">Kemp et al. 1993</xref>
###xml 120 121 120 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">.</italic>
###xml 173 176 173 176 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 230 250 230 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Sherr2">Sherr and Weber 2000</xref>
###xml 270 273 270 273 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 319 322 319 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ras</italic>
###xml 347 354 347 354 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf+/+</sup>
###xml 344 354 344 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf+/+</sup></italic>
###xml 365 372 365 372 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf+/&#8722;</sup>
###xml 362 372 362 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf+/&#8722;</sup></italic>
###xml 387 394 387 394 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf&#8722;/&#8722;</sup>
###xml 384 394 384 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf&#8722;/&#8722;</sup></italic>
###xml 464 469 462 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hras,</italic>
###xml 574 597 572 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Quintanilla1">Quintanilla et al. 1986</xref>
###xml 618 621 616 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ras</italic>
###xml 721 724 719 722 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 741 744 739 742 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 401 405 <span type="species:ncbi:10090">mice</span>
Mutations in Hras are found in more than 95% of DMBA/TPA-induced skin tumors (Quintanilla et al. 1986; Kemp et al. 1993). In vitro studies showed that mutant Ras induces p19Arf, which, in turn, inhibits Ras-induced proliferation (Sherr and Weber 2000). Thus, loss of p19Arf might reduce or eliminate the need to mutate Ras. All papillomas from p19 Arf+/+ (5/5), p19 Arf+/- (4/4), and p19 Arf-/- (5/5) mice contained the identical A-->T transversion at codon 61 of Hras, resulting in an amino acid change from glutamine to leucine and a constitutively activated Ras protein (Quintanilla et al. 1986). Thus, mutation of Ras is very strongly selected for during epithelial carcinogenesis, with or without the presence of p19Arf, and loss of p19Arf cooperates with activated Ras to accelerate tumor growth.
###end p 16
###begin title 17
###xml 53 56 53 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 67 71 <span type="species:ncbi:10090">Mice</span>
Increased Malignant Progression and Metastasis in p19Arf-Deficient Mice
###end title 17
###begin p 18
###xml 114 130 114 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Kemp1">Kemp et al. 1993</xref>
###xml 160 163 160 163 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 360 363 360 363 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 407 414 407 414 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf&#8722;/&#8722;</sup>
###xml 404 414 404 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf&#8722;/&#8722;</sup></italic>
###xml 483 490 483 490 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf+/+</sup>
###xml 480 490 480 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf+/+</sup></italic>
###xml 538 546 538 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020242-g001">Figure 1</xref>
###xml 575 582 575 582 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf&#8722;/&#8722;</sup>
###xml 572 582 572 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf&#8722;/&#8722;</sup></italic>
###xml 667 674 667 674 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf+/&#8722;</sup>
###xml 664 674 664 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf+/&#8722;</sup></italic>
###xml 790 793 790 793 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 879 882 879 882 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 1046 1053 1046 1053 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf&#8722;/&#8722;</sup>
###xml 1043 1053 1043 1053 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf&#8722;/&#8722;</sup></italic>
###xml 1082 1083 1082 1083 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1122 1129 1122 1129 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf+/&#8722;</sup>
###xml 1119 1129 1119 1129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf+/&#8722;</sup></italic>
###xml 1158 1159 1158 1159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1272 1276 1272 1276 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf</sup>
###xml 1269 1276 1269 1276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf</sup></italic>
###xml 1308 1311 1308 1311 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 374 378 <span type="species:ncbi:10090">mice</span>
###xml 415 419 <span type="species:ncbi:10090">mice</span>
###xml 491 495 <span type="species:ncbi:10090">mice</span>
###xml 583 587 <span type="species:ncbi:10090">mice</span>
###xml 654 658 <span type="species:ncbi:10090">mice</span>
###xml 675 679 <span type="species:ncbi:10090">mice</span>
###xml 736 740 <span type="species:ncbi:10090">mice</span>
###xml 1054 1058 <span type="species:ncbi:10090">mice</span>
###xml 1130 1134 <span type="species:ncbi:10090">mice</span>
###xml 1191 1195 <span type="species:ncbi:10090">mice</span>
###xml 1282 1286 <span type="species:ncbi:10090">mice</span>
The rate of malignant conversion of papillomas to carcinomas is greatly increased in the absence of p53 function (Kemp et al. 1993). To determine if loss of p19Arf had a similar effect, progression was quantified by visual inspection and confirmed by histologic analysis. The rate of conversion from papillomas to carcinomas was dramatically accelerated in p19Arf-deficient mice. Carcinomas developed in p19 Arf-/- mice as early as 14 wk after initiation, whereas papillomas from p19 Arf+/+ mice began to convert much later, after 22 wk (Figure 1C). By 28 wk, 100% of the p19 Arf-/- mice had at least one carcinoma, compared to only 25% of the wild-type mice. The p19 Arf+/- mice showed an intermediate conversion rate, with 60% of the mice bearing at least one carcinoma, indicating an p19Arf gene dosage effect on malignant progression. In addition to reducing the latency, p19Arf deficiency increased the frequency of malignant conversion. The odds of developing a carcinoma within 30 wk after DMBA administration was 8.10 times higher for p19 Arf-/- mice (95% CI (1.90, 34.56); p = 0.005) and 3.11 times higher for p19 Arf+/- mice (95% CI (0.90, 10.77); p = 0.073) compared to wild-type mice. The reduced carcinoma latency and increased conversion frequency in the p19 Arf-null mice implicate loss of p19Arf as a critical rate-limiting step in malignant SCC progression.
###end p 18
###begin p 19
###xml 158 165 158 165 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf+/&#8722;</sup>
###xml 155 165 155 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf+/&#8722;</sup></italic>
###xml 173 180 173 180 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf&#8722;/&#8722;</sup>
###xml 170 180 170 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf&#8722;/&#8722;</sup></italic>
###xml 62 66 <span type="species:ncbi:10090">mice</span>
###xml 181 185 <span type="species:ncbi:10090">mice</span>
Histologic analysis revealed that the carcinomas from control mice ranged in grade from well-differentiated to poorly differentiated SCCs. Carcinomas from p19 Arf+/- and p19 Arf-/- mice also showed a range of grades but a significant number (9/12) were characterized as spindle cell carcinomas. These were characterized by packed and spindle-shaped cells with elongated pleiomorphic nuclei and abundant abnormal mitotic figures. These cells grew in a homogenous pattern with very little evidence of the cellular organization typical of low-grade tumors. These tumors showed focal areas of squamous differentiation, indicating that they were derived from squamous epithelium.
###end p 19
###begin p 20
###xml 3 7 3 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf</sup>
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf</sup></italic>
###xml 107 110 107 110 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 228 235 228 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pbio-0020242-t001">Table 1</xref>
###xml 237 245 237 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020242-g002">Figure 2</xref>
###xml 498 506 498 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020242-g002">Figure 2</xref>
###xml 512 513 512 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020242-g002">2</xref>
###xml 659 667 659 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020242-g002">Figure 2</xref>
###xml 673 674 673 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020242-g002">2</xref>
###xml 738 745 738 745 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf&#8722;/&#8722;</sup>
###xml 735 745 735 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf&#8722;/&#8722;</sup></italic>
###xml 841 848 841 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pbio-0020242-t001">Table 1</xref>
###xml 878 882 878 882 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf</sup>
###xml 875 882 875 882 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf</sup></italic>
###xml 1051 1059 1051 1059 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020242-g001">Figure 1</xref>
###xml 1122 1129 1122 1129 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf+/+</sup>
###xml 1119 1129 1119 1129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf+/+</sup></italic>
###xml 1168 1173 1168 1173 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf+</sup>
###xml 1165 1173 1165 1173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf+</sup></italic>
###xml 1173 1175 1173 1175 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">/&#8722;</sup>
###xml 1410 1418 1410 1418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020242-g002">Figure 2</xref>
###xml 1424 1425 1424 1425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020242-g002">2</xref>
###xml 1448 1452 1448 1452 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf</sup>
###xml 1445 1452 1445 1452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf</sup></italic>
###xml 1600 1608 1600 1608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020242-g002">Figure 2</xref>
###xml 1773 1776 1773 1776 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 1887 1890 1887 1890 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 121 125 <span type="species:ncbi:10090">mice</span>
###xml 746 750 <span type="species:ncbi:10090">mice</span>
###xml 835 839 <span type="species:ncbi:10090">mice</span>
###xml 893 897 <span type="species:ncbi:10090">mice</span>
###xml 1130 1134 <span type="species:ncbi:10090">mice</span>
###xml 1176 1180 <span type="species:ncbi:10090">mice</span>
p19 Arf deficiency also increased dissemination and establishment of metastatic SCCs. Carcinoma-bearing p19Arf-deficient mice frequently presented with enlarged lymph nodes, and in several cases tumors were noted on the lungs. (Table 1; Figure 2). Histologic analysis revealed that these lymph nodes and lung tumors contained cells with features similar to the primary SCCs, including squamous differentiation, keratin pearls, high mitotic index, nuclear pleomorphism, and disturbed cell polarity (Figure 2D and 2E). Immunostaining with a keratin-specific antibody showed that these cells were epithelial in origin, confirming that they were metastatic SCCs (Figure 2F and 2G). 60% of local enlarged lymph nodes from carcinoma-bearing p19 Arf-/- mice contained such squamous carcinoma deposits, compared to 10% of those from wild-type mice (Table 1). Metastatic lesions from p19 Arf-deficient mice were seen as early as 16 wk after initiation and must have occurred very soon after or simultaneously with papilloma to carcinoma conversion (see top of Figure 1C). In contrast, only one metastatic lesion was seen in one p19 Arf+/+ mice through 36 wk of observation. p19 Arf+/- mice displayed an intermediate frequency of metastasis. Newly formed blood vessels, some measuring up to 2 mm in diameter, were seen on the underside of each tumor and appeared to lead directly to the inguinal or brachial lymph node (Figure 2A and 2B). Several primary p19 Arf-deficient carcinomas showed clear evidence of penetration of tumor cells through blood vessel walls, with intravascular rafts of tumor cells seen (Figure 2C), indicating a route by which tumor cells could migrate to distant organs through the circulation. Thus, in addition to increasing benign tumor growth, loss of p19Arf accelerated both benign to malignant conversion and metastatic spread of epithelial tumors. Tumors lacking p19Arf have a higher potential for metastatic spread.
###end p 20
###begin title 21
###xml 45 48 45 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 59 63 <span type="species:ncbi:10090">Mice</span>
Reduced p53 Expression in Papillomas from p19Arf-Deficient Mice
###end title 21
###begin p 22
###xml 97 113 97 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Kemp2">Kemp et al. 2001</xref>
###xml 346 351 346 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hras,</italic>
###xml 440 443 440 443 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 521 524 521 524 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 582 591 582 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020242-g003">Figures 3</xref>
###xml 596 597 596 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020242-g004">4</xref>
###xml 669 674 669 674 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf&#8722;</sup>
###xml 666 674 666 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf&#8722;</sup></italic>
###xml 674 676 674 676 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">/&#8722;</sup>
###xml 738 745 738 745 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf+/&#8722;</sup>
###xml 735 745 735 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf+/&#8722;</sup></italic>
###xml 973 977 973 977 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf</sup>
###xml 970 977 970 977 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf</sup></italic>
###xml 1039 1043 1039 1043 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf</sup>
###xml 1036 1043 1036 1043 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf</sup></italic>
###xml 1061 1069 1061 1069 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020242-g003">Figure 3</xref>
###xml 1137 1140 1137 1140 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 1463 1467 1463 1467 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf</sup>
###xml 1460 1467 1460 1467 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf</sup></italic>
###xml 1479 1487 1479 1487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020242-g003">Figure 3</xref>
###xml 1493 1494 1493 1494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020242-g003">3</xref>
###xml 1593 1596 1593 1596 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 1753 1756 1753 1756 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 1882 1885 1882 1885 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 677 681 <span type="species:ncbi:10090">mice</span>
###xml 746 750 <span type="species:ncbi:10090">mice</span>
###xml 919 923 <span type="species:ncbi:10090">mice</span>
###xml 1182 1186 <span type="species:ncbi:10090">mice</span>
###xml 1473 1477 <span type="species:ncbi:10090">mice</span>
The p53 expression in DMBA/TPA-induced papillomas is increased relative to adjacent normal skin (Kemp et al. 2001). As multiple signals can lead to the accumulation of p53, including activated oncogenes, DNA damage, and hypoxia, it was not clear which was operative in this setting. As nearly all carcinogen-induced papillomas carry mutations in Hras, we questioned whether increased p53 expression was due to signaling from Ras through p19Arf. Western blot analysis of nuclear lysates showed increased levels of both p19Arf and p53 in wild-type papillomas compared to normal skin (Figures 3 and 4). In contrast, p53 expression was not detectable in papillomas from p19 Arf-/- mice and was intermediate and variable in papillomas from p19 Arf+/- mice. Immunostaining of paraffin-embedded sections confirmed the Western analysis, with nuclear staining of p53 detected in the epidermal cells of papillomas from wild-type mice, reduced numbers of p53-positive cells in the p19 Arf heterozygous papillomas, and undetectable p53 staining in p19 Arf-null papillomas (Figure 3B). To determine if p53 could still be induced in the absence of p19Arf by an alternative pathway, tumor-bearing mice were irradiated with 4Gy ionizing radiation and sacrificed 4 h later, and their tissues were examined for p53 expression. Both Western blot analysis and immunostaining revealed prominent induction of p53 in basal cells of normal skin and papillomas from both wild-type and p19 Arf-null mice (Figure 3A and 3B). Thus, the induction of p53 seen in mutant Ras-containing tumors is due to signaling through p19Arf. These results provide in vivo confirmation of the model, largely derived from in vitro studies, that posits that signaling from mutant Ras acts through p19Arf to induce p53. Other pathways to activate p53, such as those initiated by DNA damage, remain functional in the absence of p19Arf.
###end p 22
###begin title 23
###xml 25 28 25 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 22 28 22 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>Arf</sup></italic>
###xml 54 60 54 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf+/&#8722;</sup>
###xml 51 60 51 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>Arf+/&#8722;</sup></italic>
###xml 61 65 <span type="species:ncbi:10090">Mice</span>
Loss of the Wild-Type p19Arf Allele in Tumors from p19Arf+/- Mice Occurs During Benign to Malignant Conversion
###end title 23
###begin p 24
###xml 3 10 3 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf+/&#8722;</sup>
###xml 0 10 0 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf+/&#8722;</sup></italic>
###xml 89 97 89 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020242-g001">Figure 1</xref>
###xml 166 170 166 170 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf</sup>
###xml 163 170 163 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf</sup></italic>
###xml 302 306 302 306 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf</sup>
###xml 299 306 299 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf</sup></italic>
###xml 347 351 347 351 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf</sup>
###xml 344 351 344 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf</sup></italic>
###xml 488 492 488 492 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf</sup>
###xml 485 492 485 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf</sup></italic>
###xml 670 674 670 674 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf</sup>
###xml 667 674 667 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf</sup></italic>
###xml 723 724 723 724 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 736 744 736 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020242-g004">Figure 4</xref>
###xml 829 832 829 832 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 896 899 896 899 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 941 944 941 944 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 1037 1045 1037 1045 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020242-g004">Figure 4</xref>
###xml 1076 1079 1076 1079 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 1137 1140 1137 1140 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 1193 1200 1193 1200 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf+/&#8722;</sup>
###xml 1190 1200 1190 1200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf+/&#8722;</sup></italic>
###xml 1271 1274 1271 1274 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 1311 1315 1311 1315 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf</sup>
###xml 1308 1315 1308 1315 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf</sup></italic>
###xml 1332 1335 1332 1335 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 1406 1413 1406 1413 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf+/&#8722;</sup>
###xml 1403 1413 1403 1413 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf+/&#8722;</sup></italic>
###xml 1492 1495 1492 1495 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 1557 1561 1557 1561 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf</sup>
###xml 1554 1561 1554 1561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf</sup></italic>
###xml 11 15 <span type="species:ncbi:10090">mice</span>
###xml 521 525 <span type="species:ncbi:10090">mice</span>
###xml 932 936 <span type="species:ncbi:10090">mice</span>
###xml 1201 1205 <span type="species:ncbi:10090">mice</span>
###xml 1246 1250 <span type="species:ncbi:10090">mice</span>
###xml 1414 1418 <span type="species:ncbi:10090">mice</span>
p19 Arf+/- mice displayed an intermediate rate of papilloma to carcinoma conversion (see Figure 1C). Two genetic models could explain this heterozygous phenotype. p19 Arf could be haploinsufficient, in which case no mutation or loss of heterozygosity (LOH) should be seen in the remaining wild-type p19 Arf allele in carcinomas. Alternatively, p19 Arf could be recessive, in which case LOH or reduction to a homozygous null state would be expected. The fate of the wild-type allele of p19 Arf in tumors from heterozygous mice was assessed by semiquantitative PCR analysis of genomic DNA. Three of 15 (20%) papillomas examined showed evidence of loss of the wild-type p19 Arf allele, compared to ten of 15 (67%) carcinomas (p = 0.0027) (Figure 4A), indicating LOH occurs primarily during malignant conversion. We next examined p19Arf expression in tumor lysates by Western blot analysis with a p19Arf-specific antibody. In wild-type mice, p19Arf protein was elevated in all papillomas and three of six carcinomas compared to normal skin (Figure 4B). Increased expression of p19Arf is consistent with activation of Ras in these tumors. p19Arf expression was also increased in papillomas from p19 Arf+/- mice but not to the levels seen in wild-type mice, indicating that p19Arf protein levels in tumors reflect p19 Arf gene dosage. p19Arf protein was reduced or undetectable in four of six carcinomas from p19 Arf+/- mice, consistent with the LOH data. Collectively, these data indicate that p19Arf expression is induced in tumors. Germline deletion of one p19 Arf allele provides a selective advantage during early tumor growth, and loss of the second allele confers an additional phenotype, destabilization of p53, and enhanced malignant progression.
###end p 24
###begin title 25
###xml 32 35 32 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
Independent Contributions of p19Arf and p53 to Tumorigenesis
###end title 25
###begin p 26
###xml 25 28 25 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 107 110 107 110 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Ar</sup>
###xml 104 110 104 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Ar</sup></italic>
###xml 110 111 110 111 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">f</sup>
###xml 149 152 149 152 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 274 277 274 277 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 332 336 332 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hras</italic>
###xml 375 379 375 379 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf</sup>
###xml 372 379 372 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf</sup></italic>
###xml 430 433 430 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 445 461 445 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Kemp1">Kemp et al. 1993</xref>
###xml 517 520 517 520 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 599 602 599 602 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 653 657 653 657 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf</sup>
###xml 650 657 650 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf</sup></italic>
###xml 662 665 662 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 734 737 734 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 828 829 828 829 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 889 893 889 893 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf</sup>
###xml 886 893 886 893 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf</sup></italic>
###xml 956 957 956 957 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1007 1015 1007 1015 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020242-g005">Figure 5</xref>
###xml 1026 1029 1026 1029 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 1023 1034 1023 1034 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>Arf</sup> /p53</italic>
###xml 1111 1114 1111 1114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 1114 1117 1114 1117 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1158 1164 1158 1164 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf&#8722;/&#8722;</sup>
###xml 1155 1164 1155 1164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>Arf&#8722;/&#8722;</sup></italic>
###xml 1172 1178 1172 1178 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf&#8722;/&#8722;</sup>
###xml 1181 1184 1181 1184 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1169 1184 1169 1184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>Arf&#8722;/&#8722;</sup>p53<sup>&#8722;/&#8722;</sup></italic>
###xml 1237 1240 1237 1240 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 1360 1364 1360 1364 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf</sup>
###xml 1357 1365 1357 1365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf</sup>-</italic>
###xml 1370 1374 1370 1374 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53-</italic>
###xml 1428 1436 1428 1436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020242-g005">Figure 5</xref>
###xml 1457 1460 1457 1460 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 1509 1512 1509 1512 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 1517 1520 1517 1520 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 1564 1567 1564 1567 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 385 389 <span type="species:ncbi:10090">mice</span>
###xml 439 443 <span type="species:ncbi:10090">mice</span>
###xml 728 732 <span type="species:ncbi:10090">mice</span>
###xml 743 747 <span type="species:ncbi:10090">mice</span>
###xml 899 903 <span type="species:ncbi:10090">mice</span>
###xml 1047 1051 <span type="species:ncbi:10090">mice</span>
###xml 1105 1109 <span type="species:ncbi:10090">mice</span>
###xml 1384 1388 <span type="species:ncbi:10090">mice</span>
The observations that p19Arf and p53 were upregulated in papillomas, that p53 expression was reduced in p19 Arf-null papillomas, and that loss of p19Arf had a similar effect on tumor progression as that of loss of p53, provide strong in vivo support of the model whereby p19Arf regulates p53 in response to mutational activation of Hras. However, enhanced tumor growth in p19 Arf-null mice, in contrast to reduced tumor growth in p53-null mice (Kemp et al. 1993), suggests additional tumor suppressor functions of p19Arf, independent of p53. To examine the effect of the combined loss of p53 and p19Arf tumor suppressors, skin tumors were induced in p19 Arf and p53 single and compound mutant littermates. Relative to wild-type mice, p53-null mice developed fewer tumors, averaging 4.05 fewer papillomas (95% CI (-6.10, -2.00); p = 0.0001) 10-16 wk after the DMBA administration, while p19 Arf-null mice averaged 2.68 more papillomas (95% CI (0.52, 4.84); p = 0.015) 18-40 wk after the DMBA administration (Figure 5A). The p19Arf /p53 double-null mice showed a papilloma multiplicity similar to wild-type mice. p53-/- tumors were also smaller, while both p19Arf-/- and p19Arf-/-p53-/- tumors were larger compared to wild-type tumors. p19Arf and p53 also affected tumor size and morphology. Wild-type papillomas were highly exophytic, while tumors from both p19 Arf- and p53-deficient mice grew in a flatter, endophytic pattern (Figure 5B). Thus, loss of p19Arf increased the number and size of both wild-type p53 and p53-null tumors, demonstrating that p53 and p19Arf contribute independently to the early stages of tumor development.
###end p 26
###begin p 27
###xml 53 56 53 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 249 252 249 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 347 351 347 351 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf</sup>
###xml 344 351 344 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf</sup></italic>
###xml 401 409 401 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020242-g005">Figure 5</xref>
###xml 420 424 420 424 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf</sup>
###xml 417 429 417 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf</sup> /p53</italic>
###xml 601 604 601 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 675 678 675 678 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 37 41 <span type="species:ncbi:10090">mice</span>
###xml 119 123 <span type="species:ncbi:10090">mice</span>
###xml 166 170 <span type="species:ncbi:10090">mice</span>
###xml 328 332 <span type="species:ncbi:10090">mice</span>
###xml 610 614 <span type="species:ncbi:10090">mice</span>
To determine whether tumor growth in mice lacking p19Arf or p53 is due to altered proliferation, additional cohorts of mice were treated with DMBA/TPA. Tumor-bearing mice 8-10 wk post DMBA treatment were injected with BrdU and sacrificed 1 h later. p53-null papillomas showed a reduced BrdU labeling index compared to wild-type mice, while the p19 Arf-null tumors showed a higher BrdU labeling index (Figure 5C). The p19 Arf /p53 double-null papillomas showed a proliferative index similar to that of wild-type tumors. Thus, decreased proliferation contributes to the reduced tumor growth seen in the p53-null mice. Apoptotic cells were very rare in papillomas regardless of p53 genotype or radiation exposure (apoptotic index over 40-fold less than proliferation index) (unpublished data). Thus, p53-regulated apoptosis does not appear to play a major role in SCC development, at least at the papilloma stage.
###end p 27
###begin title 28
###xml 24 27 24 27 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 21 32 21 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>Arf</sup> /p53</italic>
###xml 49 53 <span type="species:ncbi:10090">Mice</span>
Tumor Progression in p19Arf /p53 Compound Mutant Mice
###end title 28
###begin p 29
###xml 19 22 19 22 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 121 127 121 127 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf&#8722;/&#8722;</sup>
###xml 132 135 132 135 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 118 136 118 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>Arf&#8722;/&#8722;</sup>, p53<sup>&#8722;/&#8722;</sup>,</italic>
###xml 144 150 144 150 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf&#8722;/&#8722;</sup>
###xml 153 156 153 156 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 141 156 141 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>Arf&#8722;/&#8722;</sup>p53<sup>&#8722;/&#8722;</sup></italic>
###xml 214 218 214 218 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf</sup>
###xml 211 219 211 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf</sup>-</italic>
###xml 224 227 224 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 283 291 283 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020242-g006">Figure 6</xref>
###xml 358 365 358 365 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf&#8722;/&#8722;</sup>
###xml 355 365 355 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf&#8722;/&#8722;</sup></italic>
###xml 385 388 385 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 402 405 402 405 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 410 413 410 413 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 398 414 398 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(p53<sup>+/+</sup>, p53<sup>+/&#8722;</sup>,</italic>
###xml 421 424 421 424 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 418 425 418 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>&#8722;/&#8722;</sup>)</italic>
###xml 427 435 427 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020242-g006">Figure 6</xref>
###xml 476 479 476 479 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 564 571 564 571 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf&#8722;/&#8722;</sup>
###xml 561 571 561 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf&#8722;/&#8722;</sup></italic>
###xml 579 586 579 586 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf&#8722;/&#8722;</sup>
###xml 589 592 589 592 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 576 592 576 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf&#8722;/&#8722;</sup>p53<sup>&#8722;/&#8722;</sup></italic>
###xml 644 647 644 647 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 641 647 641 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>&#8722;/&#8722;</sup></italic>
###xml 684 692 684 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020242-g005">Figure 5</xref>
###xml 737 740 737 740 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 366 370 <span type="species:ncbi:10090">mice</span>
###xml 593 597 <span type="species:ncbi:10090">mice</span>
###xml 648 652 <span type="species:ncbi:10090">mice</span>
To determine if p19Arf and p53 cooperate during tumor progression, papilloma to carcinoma conversion was evaluated in p19Arf-/-, p53-/-, and p19Arf-/-p53-/- littermates. Tumor progression was accelerated in all p19 Arf- and p53-deficient genotypes compared to wild-type littermates (Figure 6A). Carcinoma latency and multiplicity was almost identical for p19 Arf-/- mice regardless of p53 genotype (p53+/+, p53+/-, or p53-/-) (Figure 6A), indicating no cooperation between p19Arf and p53 for malignant conversion per se. However, the size of carcinomas in both p19 Arf-/- and p19 Arf-/-p53-/- mice was considerably greater than that seen in p53-/- mice at comparable time points (see Figure 5B). This confirms a significant impact of p19Arf on suppressing tumor growth that does not require p53.
###end p 29
###begin p 30
###xml 6 9 6 9 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 3 9 3 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>+/&#8722;</sup></italic>
###xml 112 128 112 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Kemp1">Kemp et al. 1993</xref>
###xml 137 140 137 140 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 255 258 255 258 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 275 278 275 278 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 272 278 272 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>+/&#8722;</sup></italic>
###xml 300 304 300 304 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf</sup>
###xml 297 304 297 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf</sup></italic>
###xml 320 327 320 327 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf+/+</sup>
###xml 332 339 332 339 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf+/&#8722;</sup>
###xml 315 340 315 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">( p19<sup>&#8202;Arf+/+</sup>, p19<sup>&#8202;Arf+/&#8722;</sup>,</italic>
###xml 348 355 348 355 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf&#8722;/&#8722;</sup>
###xml 345 356 345 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf&#8722;/&#8722;</sup>)</italic>
###xml 382 385 382 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 471 478 471 478 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf+/+</sup>
###xml 481 484 481 484 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 468 484 468 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf+/+</sup>p53<sup>+/&#8722;</sup></italic>
###xml 517 520 517 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 567 574 567 574 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf+/&#8722;</sup>
###xml 577 580 577 580 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 564 580 564 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf+/&#8722;</sup>p53<sup>+/&#8722;</sup></italic>
###xml 582 583 582 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 596 603 596 603 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf&#8722;/&#8722;</sup>
###xml 606 609 606 609 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 593 609 593 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf&#8722;/&#8722;</sup>p53<sup>+/&#8722;</sup></italic>
###xml 611 612 611 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 651 654 651 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 656 664 656 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020242-g006">Figure 6</xref>
###xml 705 712 705 712 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf+/+</sup>
###xml 715 718 715 718 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 702 719 702 719 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf+/+</sup>p53<sup>+/&#8722;</sup>,</italic>
###xml 751 757 751 757 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf+/&#8722;</sup>
###xml 760 763 760 763 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 747 764 747 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19&#8202;<sup>Arf+/&#8722;</sup>p53<sup>+/&#8722;</sup>,</italic>
###xml 797 804 797 804 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf&#8722;/&#8722;</sup>
###xml 807 810 807 810 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 794 810 794 810 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf&#8722;/&#8722;</sup>p53<sup>+/&#8722;</sup></italic>
###xml 812 813 812 813 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 838 841 838 841 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 864 867 864 867 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 946 949 946 949 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 10 14 <span type="species:ncbi:10090">mice</span>
###xml 279 283 <span type="species:ncbi:10090">mice</span>
###xml 485 489 <span type="species:ncbi:10090">mice</span>
###xml 618 622 <span type="species:ncbi:10090">mice</span>
In p53+/- mice there is strong selective pressure to lose the wild-type allele during conversion to malignancy (Kemp et al. 1993). As p19Arf regulates p53, we next wished to determine if the selective pressure to lose p53 was reduced in the absence of p19Arf. Tumors from p53+/- mice of all three p19 Arf genotypes ( p19 Arf+/+, p19 Arf+/-, and p19 Arf-/-) were assessed for LOH of p53 by semiquantitative PCR analysis of genomic DNA. Two out of seven papillomas from p19 Arf+/+p53+/- mice show loss of the remaining p53 allele, while all papillomas examined from p19 Arf+/-p53+/- (n = 8) and p19 Arf-/-p53+/- (n = 8) mice show retention of wild-type p53 (Figure 6B). Seven of 14 (50%) carcinomas from p19 Arf+/+p53+/-, and three of 14 (21%) from p19 Arf+/-p53+/-, but only one of 12 (8%) from p19 Arf-/-p53+/- (p = 0.036) showed loss of p53. Thus, deletion of p19Arf disrupts the activation of p53 and thereby reduces selection for mutations in p53 during malignant progression.
###end p 30
###begin title 31
Discussion
###end title 31
###begin p 32
###xml 113 117 113 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hras</italic>
###xml 147 150 147 150 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 144 150 144 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>Arf</sup></italic>
###xml 155 158 155 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 180 183 180 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ras</italic>
###xml 277 280 277 280 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 457 461 457 461 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf</sup>
###xml 454 461 454 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf</sup></italic>
###xml 530 534 530 534 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf</sup>
###xml 527 534 527 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf</sup></italic>
###xml 626 629 626 629 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 700 703 700 703 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 751 754 751 754 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 882 885 882 885 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 936 939 936 939 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 932 939 932 939 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19&#8202;<sup>Arf</sup></italic>
###xml 1014 1017 1014 1017 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 1058 1061 1058 1061 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 1160 1163 1160 1163 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 1251 1254 1251 1254 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 1309 1312 1309 1312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ras</italic>
Using a multistage model of tumor progression, we have examined the functional interactions between the oncogene Hras and the tumor suppressors p19Arf and p53. Somatic mutation of Ras is an early and frequent event in this model of tumor development. Against this backdrop, p19Arf has at least two distinct tumor suppressor properties, which act at different stages of tumor development and which show a range of gene dosage effects. Loss of one or both p19 Arf alleles leads to accelerated growth of benign tumors, indicating p19 Arf is partially haploinsufficient for suppression of this early growth phenotype. Although p19Arf regulates p53 at this stage, suppression of tumor growth per se by p19Arf does not appear to be mediated through p53. p19Arf also inhibits the benign to malignant transition and subsequent tumor cell dissemination and metastasis, and this effect of p19Arf is, in contrast, mediated through p53. LOH of p19 Arf occurs preferentially in malignant tumors, indicating complete loss of p19Arf is favored during progression. Thus, p19Arf inhibits several stages in Ras-driven tumor progression. Furthermore, Ras is connected to both p19Arf and p53 through a signaling pathway, indicating that selection for mutations in the p19Arf / p53 pathway are a direct consequence of the initial Ras mutation.
###end p 32
###begin title 33
###xml 8 11 8 11 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
Ras, p19Arf, p53, and Early Tumor Growth
###end title 33
###begin p 34
###xml 21 25 21 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hras</italic>
###xml 105 108 105 108 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 184 188 184 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hras</italic>
###xml 269 272 269 272 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 437 440 437 440 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 502 509 502 509 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf&#8722;/&#8722;</sup>
###xml 499 509 499 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf&#8722;/&#8722;</sup></italic>
###xml 541 544 541 544 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 710 713 710 713 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 770 774 770 774 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf</sup>
###xml 767 774 767 774 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf</sup></italic>
###xml 892 910 892 910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Ko1">Ko and Prives 1996</xref>
###xml 912 935 912 935 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Giaccia1">Giaccia and Kastan 1998</xref>
###xml 949 952 949 952 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 128 132 <span type="species:ncbi:10090">mice</span>
The observation that Hras mutations are found at high frequency in papillomas from wild-type and both p19Arf- and p53-deficient mice indicates that squamous epithelial cells harboring Hras mutations have a strong selective advantage, with or without the presence of p19Arf or p53. This permits analysis of the effects of Ras on defined genetic backgrounds in the natural setting of tumor cell evolution. The expression levels of both p19Arf and p53 were increased in wild-type papillomas but not in p19 Arf-/- papillomas, indicating that p19Arf regulates p53 in response to activated Ras in vivo. However, other signals to induce p53, such as those stemming from DNA damage, remain intact in the absence of p19Arf, as shown by the rapid increase in p53 in irradiated p19 Arf-null tumors. Thus, of the many stimuli that have been shown to activate p53 using a variety of experimental systems (Ko and Prives 1996; Giaccia and Kastan 1998), the Ras-p19Arf pathway appears to be the major signal that operates during SCC development. This indicates that p53 activation is an intrinsic consequence of the oncogenic pathway that drives tumor growth, and is not due to other microenvironmental factors (e.g., those induced by hypoxia or due to lack of survival factors) or exogenous stimuli (e.g., DNA damage inducers). However, it remains possible that these other modes of p53 activation might predominate in other tumor types or in other circumstances.
###end p 34
###begin p 35
###xml 30 33 30 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 81 84 81 84 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 139 142 139 142 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 357 360 357 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ras</italic>
###xml 540 559 540 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Palmero1">Palmero et al. 1998</xref>
###xml 561 578 561 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Zindy1">Zindy et al. 1998</xref>
###xml 580 597 580 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Lin1">Lin and Lowe 2001</xref>
###xml 773 792 773 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Lowe1">Lowe and Ruley 1993</xref>
###xml 794 813 794 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Serrano1">Serrano et al. 1997</xref>
###xml 815 837 815 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Sherr1">Sherr and DePinho 2000</xref>
###xml 1002 1006 1002 1006 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hras</italic>
###xml 238 242 <span type="species:ncbi:10090">mice</span>
Despite the fact that both p19Arf and p53 were induced in papillomas, loss of p19Arf or p53 had opposite effects on early tumor growth. p19Arf deficiency resulted in increased tumor cell proliferation and tumor growth while p53-deficient mice had reduced tumor cell proliferation, tumor numbers, and tumor size. The observation that tumors harboring mutant Ras grew faster in the presence of p53 than in the absence of p53 differs from in vitro studies, in which ectopically expressed Ras induces p53-dependent growth arrest or senescence (Palmero et al. 1998; Zindy et al. 1998; Lin and Lowe 2001). These different outcomes are likely due to different experimental conditions. Ex vivo culture per se induces stress, which can further induce p53 and accelerate senescence (Lowe and Ruley 1993; Serrano et al. 1997; Sherr and DePinho 2000). Moreover, the levels of active Ras protein likely differ; our autochthonous tumor model begins with a single cell that has undergone a mutation at the endogenous Hras locus, and subsequent tumor growth occurs in the context of surrounding normal cells. Locally produced growth factors or TPA treatment may attenuate the effect of Ras on p53, effectively dampening the response. Thus, the absolute levels of both Ras and p53, as well as cell type involved and the local cellular ecology, may dictate the outcome.
###end p 35
###begin p 36
###xml 0 21 0 21 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Greenhalgh1">Greenhalgh al. (1996)</xref>
###xml 49 52 49 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ras</italic>
###xml 88 91 88 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 612 633 612 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Donehower1">Donehower et al. 1992</xref>
###xml 682 685 682 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 696 711 696 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Vogelstein1">Vogelstein 1990</xref>
###xml 871 874 871 874 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 1211 1214 1211 1214 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 1322 1325 1322 1325 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 606 610 <span type="species:ncbi:10090">mice</span>
###xml 652 660 <span type="species:ncbi:9606">patients</span>
###xml 838 843 <span type="species:ncbi:9606">human</span>
Greenhalgh al. (1996) also reported reduction in Ras-transgene-induced skin tumors in a p53-null background. We suggest that the acute effect of a constitutively active oncogene driving cellular proliferation, combined with lack of cell cycle checkpoints due to p53 deficiency, may generate excessive genetic instability, which may initially impair overall cellular fitness. This may be especially true at the early post-initiation stage where a small number of incipient tumor cells are competing with surrounding normal cells. This idea is consistent with the longstanding observation that p53-deficient mice (Donehower et al. 1992), and Li-Fraumeni patients who carry a germline p53 mutation (Vogelstein 1990), rarely develop multiple tumors, which would be expected if loss of p53 provided an early selective advantage. Also, in many human malignancies, mutations in p53 are infrequent in early premalignant lesions and much more common in late-stage disease, indicating a long latency between oncogene activation and loss of p53. Further genetic or epigenetic changes may be required for a cell to adapt to the combined effect of a dominant oncogene and loss of p53 to gain a fitness advantage. Loss of p19Arf appears to be one such change, as reduced tumor growth due to the absence of p53 was rescued by loss of p19Arf.
###end p 36
###begin p 37
###xml 12 15 12 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 72 75 72 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 157 160 157 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 224 228 224 228 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf</sup>
###xml 221 228 221 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf</sup></italic>
###xml 297 300 297 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 312 333 312 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Donehower1">Donehower et al. 1992</xref>
###xml 335 353 335 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Kamijo2">Kamijo et al. 1999</xref>
###xml 378 381 378 381 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 374 381 374 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19&#8202;<sup>Arf</sup></italic>
###xml 386 389 386 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 510 527 510 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Weber2">Weber et al. 2000</xref>
###xml 529 546 529 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Moore1">Moore et al. 2003</xref>
###xml 619 623 618 622 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf</sup>
###xml 616 623 615 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf</sup></italic>
###xml 628 631 627 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 691 695 690 694 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf</sup>
###xml 688 695 687 694 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf</sup></italic>
###xml 699 702 698 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 710 727 709 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Weber2">Weber et al. 2000</xref>
###xml 746 749 745 748 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 856 876 855 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Ruas1">Ruas and Peters 1998</xref>
###xml 878 900 877 899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Vonlanthen1">Vonlanthen et al. 1998</xref>
###xml 985 988 984 987 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 1091 1106 1090 1105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Kuo1">Kuo et al. 2003</xref>
###xml 1197 1200 1196 1199 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 1286 1289 1285 1288 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 1307 1328 1306 1327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Yarbrough1">Yarbrough et al. 2002</xref>
###xml 1334 1337 1333 1336 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 1395 1415 1394 1414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Sugimoto1">Sugimoto et al. 2003</xref>
###xml 1459 1476 1454 1471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Rocha1">Rocha et al. 2003</xref>
###xml 1491 1494 1486 1489 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 1570 1573 1565 1568 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 1592 1612 1587 1607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-McKeller1">McKeller et al. 2002</xref>
###xml 1688 1691 1683 1686 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 234 238 <span type="species:ncbi:10090">mice</span>
###xml 306 310 <span type="species:ncbi:10090">mice</span>
###xml 356 360 <span type="species:ncbi:10090">Mice</span>
###xml 591 594 <span type="species:ncbi:8790">Emu</span>
###xml 789 794 <span type="species:ncbi:9606">human</span>
###xml 1225 1230 <span type="species:ncbi:9606">human</span>
Although p19Arf regulates p53, suppression of tumor growth per se by p19Arf does not appear to be mediated through p53. Other reports have suggested that p19Arf has tumor suppressor functions that are independent of p53. p19 Arf-null mice show a broader spectrum of spontaneous tumors compared to p53-null mice (Donehower et al. 1992; Kamijo et al. 1999). Mice lacking both p19 Arf and p53 showed a wider range of tumor types than animals lacking either gene alone, and many developed multiple primary tumors (Weber et al. 2000; Moore et al. 2003). Premalignant B-cells expressing oncogenic Emu-myc and lacking both p19 Arf and p53 proliferated at a faster rate than cells lacking either p19 Arf or p53 alone (Weber et al. 2000). Indeed, both p19Arf and p53 are lost in a wide spectrum of human cancers, both familial and sporadic, at very high frequency (Ruas and Peters 1998; Vonlanthen et al. 1998). Microarray and GeneChip analysis of genes induced by a conditionally regulated p19Arf has identified members of the B-cell translocation gene family whose induction is independent of p53 (Kuo et al. 2003). Expression of these genes inhibits cell proliferation and induces cell cycle arrest. p19Arf can colocalize with the human replication protein A, suggesting a direct role for p19Arfin DNA synthesis (Yarbrough et al. 2002). p19Arf has also been shown to inhibit ribosomal RNA processing (Sugimoto et al. 2003) and to repress NF-kappaB transactivation (Rocha et al. 2003). Finally, p19Arf regulates vascular regression independent of p53, suggesting a role for p19Arf in angiogenesis. (McKeller et al. 2002). The functional relevance of these phenotypes for tumor suppression by p19Arf remains to be elucidated.
###end p 37
###begin title 38
###xml 8 11 8 11 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
Ras, p19Arf, p53, and Malignant Progression
###end title 38
###begin p 39
###xml 564 567 564 567 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 728 731 728 731 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 778 781 778 781 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 878 881 878 881 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 914 917 914 917 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 942 945 942 945 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 987 990 987 990 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 1023 1044 1023 1044 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Schmitt1">Schmitt et al. (1999)</xref>
###xml 1106 1109 1105 1108 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1103 1109 1102 1108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>&#8722;/&#8722;</sup></italic>
###xml 1217 1220 1215 1218 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 1299 1302 1297 1300 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 1394 1397 1392 1395 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 1798 1801 1796 1799 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 587 591 <span type="species:ncbi:10090">mice</span>
###xml 605 609 <span type="species:ncbi:10090">mice</span>
###xml 792 796 <span type="species:ncbi:10090">mice</span>
###xml 1095 1098 <span type="species:ncbi:8790">Emu</span>
###xml 1110 1114 <span type="species:ncbi:10090">mice</span>
###xml 1127 1130 <span type="species:ncbi:8790">Emu</span>
###xml 1135 1139 <span type="species:ncbi:10090">mice</span>
In the DMBA/TPA model, conversion of papillomas to carcinomas is a relatively rare event and can take up to 6-12 mo. Phenotypes associated with conversion include loss of basement membrane integrity, invasion of epithelial tumor cells into the dermis, loss of differentiation, and increased cellular atypia. Even more rarely, these carcinoma cells can metastasize, which involves additional phenotypic changes including, extravasation, migration, attachment, and establishment of tumor growth in an ectopic tissue. Although benign tumor growth differed between p19Arf- and p53-deficient mice, both mutant mice showed dramatically accelerated progression to malignancy and rapid metastasis. Thus, benign tumors lacking either p19Arf or p53 are at high risk for metastasis. In p19Arf-deficient mice, progression was similar with or without the presence of p53 and did not involve p53 LOH, indicating that loss of p19Arf decreased selection for p53 mutations during progression and that p19Arf acts through p53 at this stage. Schmitt et al. (1999) also reported increased lymphoma dissemination in Emu-myc p53-/- mice relative to Emu-myc mice alone. From a clinical perspective, then, the most relevant effect of the p19Arf-p53 pathway may be to inhibit malignant conversion and metastasis. Loss of p19Arf and/or p53 can increase progression and metastasis by several mechanisms. Deficiency in p19Arf or p53 could indirectly affect progression via increased genetic instability, increased generation of mutants, and accelerated tumor evolution. This view postulates the existence of a distinct class of genes whose dysfunction increases progression and metastasis. It also requires a series of clonal evolutionary steps to select for cells carrying mutations in these genes. Alternatively, loss of p19Arf or p53 can directly affect cellular phenotypes associated with progression through transcriptional regulation, or by relieving inhibition of Ras signaling.
###end p 39
###begin p 40
###xml 8 11 8 11 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 215 218 215 218 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 567 583 567 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Cano1">Cano et al. 1996</xref>
###xml 718 740 718 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Birchmeier1">Birchmeier et al. 1993</xref>
###xml 742 758 742 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Perl1">Perl et al. 1998</xref>
###xml 784 787 784 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 1032 1035 1032 1035 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 1167 1170 1167 1170 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 1393 1396 1393 1396 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 1190 1194 <span type="species:ncbi:10090">mice</span>
Both p19Arf- and p53-deficient papillomas displayed several characteristics consistent with early malignancy. Conversion of papillomas to carcinomas is first characterized by a flattening, endophytic transition. p19Arf- and p53-deficient papillomas had this morphology from the outset, suggesting an early propensity for malignant conversion. More detailed histological and immunochemical characterization showed that p53-deficient papillomas were more dysplastic and had aberrant expression of differentiation markers such as E-cadherin, P-cadherin, and Keratin-13 (Cano et al. 1996). E-cadherin is a critical component of cell-cell adhesion and its down regulation is strongly associated with malignant progression (Birchmeier et al. 1993; Perl et al. 1998). That these "high risk" p53-null papillomas exhibited these early malignant features argues for a more direct effect of p53 on cellular phenotypes associated with progression. In addition, there was a lack of correlation between papilloma size and propensity to progress. p53-null papillomas were fewer and smaller, yet these showed the most rapid progression. Finally, metastasis of skin tumors in both p19Arf- and p53-deficient mice was observed within a matter of days after papilloma to carcinoma conversion, again, irrespective of precursor tumor size. Collectively, these data are inconsistent with a model in which loss of p19Arf or p53 indirectly accelerates tumor progression by accelerating a series of independent genetic events, each followed by clonal selection, and instead favor a more direct model.
###end p 40
###begin p 41
###xml 106 109 106 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 408 427 408 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Lazarov1">Lazarov et al. 2002</xref>
###xml 429 446 429 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Dajee1">Dajee et al. 2003</xref>
###xml 448 463 448 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Kim1">Kim et al. 2003</xref>
###xml 504 519 504 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Oft1">Oft et al. 1996</xref>
###xml 521 539 521 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Zondag1">Zondag et al. 2000</xref>
###xml 556 575 556 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Arbiser1">Arbiser et al. 1997</xref>
###xml 577 597 577 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Casanova1">Casanova et al. 2002</xref>
###xml 616 636 616 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Pozzatti1">Pozzatti et al. 1986</xref>
###xml 638 654 638 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Webb1">Webb et al. 1998</xref>
###xml 656 671 656 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Oft2">Oft et al. 2002</xref>
###xml 673 693 673 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Varghese1">Varghese et al. 2002</xref>
###xml 769 789 769 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Campbell1">Campbell et al. 1998</xref>
###xml 929 949 929 949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Campbell1">Campbell et al. 1998</xref>
###xml 1035 1053 1035 1053 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Ozanne1">Ozanne et al. 2000</xref>
###xml 1055 1073 1055 1073 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Jochum1">Jochum et al. 2001</xref>
###xml 1075 1092 1075 1092 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Young1">Young et al. 2003</xref>
###xml 1220 1236 1220 1236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Saez1">Saez et al. 1995</xref>
###xml 1342 1358 1342 1358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Webb1">Webb et al. 1998</xref>
###xml 1539 1555 1539 1555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Zohn1">Zohn et al. 1998</xref>
###xml 1845 1860 1845 1860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Oft1">Oft et al. 1996</xref>
###xml 1862 1866 1862 1866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Oft2">2002</xref>
###xml 1868 1886 1868 1886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Zondag1">Zondag et al. 2000</xref>
###xml 2308 2325 2308 2325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Zuber1">Zuber et al. 2000</xref>
###xml 1099 1114 <span type="species:ncbi:10090">transgenic mice</span>
We suggest that Ras may be a major driving force for multiple steps in tumor progression, with loss of p19Arf and p53 playing a facilitating role. In addition to the well-known effects of Ras on proliferation, consistent with an early role in neoplasia, Ras also contributes to a number of phenotypes that are involved in malignant progression, including metastasis. Ras induces cell motility, invasiveness (Lazarov et al. 2002; Dajee et al. 2003; Kim et al. 2003), epithelial to mesenchymal transition (Oft et al. 1996; Zondag et al. 2000), angiogenesis (Arbiser et al. 1997; Casanova et al. 2002), and metastasis (Pozzatti et al. 1986; Webb et al. 1998; Oft et al. 2002; Varghese et al. 2002). Ras activates a number of signaling cascades that drive these processes (Campbell et al. 1998). For example, Ras activation of the Raf-MAPK signaling cascade regulates the activities of nuclear transcription factors, including AP-1 (Campbell et al. 1998). In addition to regulating proliferation, AP-1 induces a motility/invasion program (Ozanne et al. 2000; Jochum et al. 2001; Young et al. 2003). Ras transgenic mice that lack Fos, a component of AP-1, develop benign skin tumors, but these fail to convert to carcinomas (Saez et al. 1995). MAPK activation also determines the ability of Ras-transformed fibroblasts to metastasize to the lung (Webb et al. 1998). Oncogenic Ras also works in concert with the Rho family of GTPases to regulate the intracellular actin cytoskeleton and promote cell motility and invasion leading to metastasis (Zohn et al. 1998). Sustained signaling by oncogenic Ras can permanently downregulate Rac activity and lead to an epithelial to mesenchymal transition. This transition is associated with changes in gene expression, loss of E-cadherin-mediated cell-cell adhesions, and increased invasiveness of tumor cells (Oft et al. 1996, 2002; Zondag et al. 2000). This allows the cell to become mobile, invade surrounding tissue, and establish metastatic sites. An additional link between Ras and tumor progression was demonstrated in a genome-wide survey of Ras transformation targets that identified a significant increase in expression of genes triggering invasion and metastasis, such as the laminin receptor, collagenase (Mmp-1), stromolysin (Mmp-3), and the Cd44 glycoprotein (Zuber et al. 2000). Ras also repressed genes involved in anti-invasive or anti-angiogenic activity, such as syndecan-2, tissue inhibitor of metalloproteases-2 (Timp-2), and thrombospondin-1.
###end p 41
###begin p 42
###xml 126 129 126 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ras</italic>
###xml 226 229 226 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ras</italic>
###xml 379 403 379 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Bremner1">Bremner and Balmain 1990</xref>
###xml 405 425 405 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Buchmann1">Buchmann et al. 1991</xref>
###xml 459 462 459 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ras</italic>
###xml 542 560 542 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Schwab1">Schwab et al. 1983</xref>
###xml 562 580 562 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Tanaka1">Tanaka et al. 1986</xref>
###xml 582 605 582 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Winter1">Winter and Perucho 1986</xref>
###xml 607 625 607 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Yokota1">Yokota et al. 1986</xref>
###xml 718 733 718 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Hoa1">Hoa et al. 2002</xref>
###xml 735 750 735 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Soh1">Soh et al. 2002</xref>
###xml 1013 1032 1013 1032 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Shields1">Shields et al. 2000</xref>
###xml 1181 1196 1181 1196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Yin1">Yin et al. 1992</xref>
Further support for a continual involvement of Ras in tumor progression is indicated by the increase in copy number of mutant Ras alleles that is observed during tumor progression. In the DMBA/TPA skin tumor model, the mutant Ras allele is frequently duplicated in papillomas and amplified to multiple copies in carcinomas, especially in the most aggressive spindle cell tumors (Bremner and Balmain 1990; Buchmann et al. 1991). Increased expression of mutant Ras genes by gene amplification or other mechanisms is found in other tumor types (Schwab et al. 1983; Tanaka et al. 1986; Winter and Perucho 1986; Yokota et al. 1986) and has been shown to promote the growth of head and neck SCC and carcinoma of the cervix (Hoa et al. 2002; Soh et al. 2002). This indicates that there is a selective advantage to progressively increasing levels of Ras throughout tumor progression. Quantitative differences in Ras activity are known to differentially activate signaling pathways leading to different cellular outcomes (Shields et al. 2000). Loss of p53 may facilitate the increase in Ras levels, in that cells with inactivated p53 show greatly increased frequency of gene amplification (Yin et al. 1992).
###end p 42
###begin p 43
###xml 18 21 18 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ras</italic>
###xml 151 159 151 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020242-g007">Figure 7</xref>
###xml 185 188 185 188 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 279 282 279 282 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 423 426 423 426 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 527 530 527 530 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
Thus, mutation in Ras is much more than the initiating event: it directly contributes to many of the phenotypes associated with malignant progression (Figure 7). As Ras induces both p19Arf and p53, and both are antagonistic to Ras, we suggest that an important consequence of p19Arf and p53 loss is that it permits increased Ras levels and signaling, fueling further tumor progression. In addition to counteracting Ras, p19Arf and p53 likely contribute to tumor suppression through additional pathways. For example, loss of p19Arf increases tumor growth, and loss of p53 confers resistance to apoptosis and loss of cell cycle checkpoints, leading to genetic instability. The observation that oncogene mutations are linked to tumor suppressor gene activation through mechanistic signaling pathways indicates that selective pressure in favor of tumor suppressor gene mutations originates from the initial oncogenic lesion and is thus intrinsic to the tumor.
###end p 43
###begin title 44
Materials and Methods
###end title 44
###begin title 45

###end title 45
###begin title 46
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice
###end title 46
###begin p 47
###xml 3 6 3 6 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 93 111 93 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Kamijo1">Kamijo et al. 1997</xref>
###xml 177 184 177 184 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf&#8722;/&#8722;</sup>
###xml 174 184 174 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf&#8722;/&#8722;</sup></italic>
###xml 335 336 335 336 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 393 400 393 400 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf&#8722;/&#8722;</sup>
###xml 405 412 405 412 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf+/&#8722;</sup>
###xml 390 413 390 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf&#8722;/&#8722;</sup>, p19<sup>&#8202;Arf+/&#8722;</sup>,</italic>
###xml 421 428 421 428 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf+/+</sup>
###xml 418 428 418 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf+/+</sup></italic>
###xml 690 692 687 689 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 17 21 <span type="species:ncbi:10090">mice</span>
###xml 185 189 <span type="species:ncbi:10090">mice</span>
###xml 367 371 <span type="species:ncbi:10090">mice</span>
###xml 481 485 <span type="species:ncbi:10090">mice</span>
###xml 769 774 <span type="species:ncbi:10090">mouse</span>
###xml 801 805 <span type="species:ncbi:10090">Mice</span>
p19Arf-deficient mice (C57BL/6 x 129SvJ) were provided by Martine Roussel and Charles Sherr (Kamijo et al. 1997). To increase their susceptibility to skin tumor development, p19 Arf-/- mice were backcrossed to the susceptible NIH/Ola strain (Harlan Olac, Oxfordshire, United Kingdom), and carcinogenesis studies were performed on the F3 littermates of this cross. 20 mice of each genotype, p19 Arf-/-, p19 Arf+/-, and p19 Arf+/+ were treated. The backs of 8-wk-old male and female mice were shaved and treated with a single application of DMBA (25 mug in 200 mul of acetone; Sigma, St. Louis, Missouri, United States) followed a week later by twice weekly applications of TPA (200 mul of 10-4 M solution in acetone) for 15 wk. The number and size of papillomas on each mouse were recorded every 2 wk. Mice were sacrificed if moribund or following detection of carcinomas. Tumors were frozen for DNA extraction and/or fixed in formalin to be processed and stained with hematoxylin/eosin (H&E) for histological examination.
###end p 47
###begin p 48
###xml 19 22 19 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 24 45 24 45 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Donehower1">Donehower et al. 1992</xref>
###xml 49 50 49 50 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sub>
###xml 88 92 88 92 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf</sup>
###xml 85 92 85 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf</sup></italic>
###xml 105 106 105 106 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 145 153 145 153 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;&#8202;Arf+/&#8722;</sup>
###xml 157 160 157 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 142 160 142 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;&#8202;Arf+/&#8722;</sup>&#8202;p53<sup>+/&#8722;</sup></italic>
###xml 229 233 229 233 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf</sup>
###xml 226 238 226 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf</sup> /p53</italic>
###xml 248 249 248 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">.</italic>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 125 129 <span type="species:ncbi:10090">mice</span>
###xml 161 165 <span type="species:ncbi:10090">mice</span>
###xml 173 177 <span type="species:ncbi:10090">mice</span>
###xml 261 265 <span type="species:ncbi:10090">mice</span>
Mice deficient for p53 (Donehower et al. 1992) (F7 backcross to NIH) were crossed to p19 Arf-deficient (F4 backcross to NIH) mice to generate p19  Arf+/- p53+/- mice. These mice were intercrossed to generate all nine possible p19 Arf /p53 genotypes. Some 20-30 mice of each genotype were subjected to the same DMBA/TPA protocol and monitored as described above.
###end p 48
###begin title 49
Immunoblotting
###end title 49
###begin p 50
###xml 119 140 119 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Schreiber1">Schreiber et al. 1989</xref>
###xml 895 898 894 897 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
In order to remove abundant keratin present in papillomas and carcinomas, nuclear extracts were prepared as described (Schreiber et al. 1989) with modifications. Pieces of skin or tumor were ground in liquid nitrogen with a mortar and pestle, and the resulting powder was dissolved in buffer A and further homogenized for 1 min on ice (PowerGen 125, Fischer Scientific, Pittsburgh, Pennsylvania, United States). Buffers A and C both contained 1 mM DTT, 0.4 mg/ml Pefablock, 25 mg/ml Aprotinin, 10 mg/ml Pepstatin, and 10 mg/ml leupeptin (Roche, Alameda, California, Unites States) to inhibit proteases. Protein concentrations were standardized using the Bradford assay (Bio-Rad, Hercules, California, United States) and equal loading (50 mug/lane) was confirmed by Ponceau S staining of the nylon membrane after blotting. Western blot analysis was performed using specific antibodies against p19Arf (Novus Biologicals, Littleton, Colorado, United States) and p53 (Novocastra Laboratories, Newcastle-upon-Tyne, United Kingdom).
###end p 50
###begin title 51
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hras</italic>
Hras sequencing
###end title 51
###begin p 52
###xml 167 171 167 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hras</italic>
###xml 216 217 216 217 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Genomic DNA was prepared from tumor and normal tissue by QIAamp DNA Mini Kit (Qiagen, Valencia, California, United States). A 400-bp PCR fragment containing exon 2 of Hras was amplified with standard PCR (3.0 mM MgCl2 andannealing for 2 min at 37 degreesC with 40 cycles), with 5'-GACTCCTACCGGAAACAGGT-3' and 5'-CTGTACTGATGGATGTCCTC-3' primers. We used the internal primer 5'-TGGTCATTGATGGGGAGACA-3' to sequence exon 2, using PE Biosystems (Applied Biosystems, Foster City, Calfornia, United States) Dye-Terminator and Big-Dye cycle sequencing.
###end p 52
###begin title 53
Histological analysis
###end title 53
###begin p 54
Sections of normal skin, papillomas, carcinomas, and other organs were removed and fixed in 10% normal buffered formalin for 4 h. After fixation, tissues were processed and then embedded in paraffin. From the tissues, 4-mum sections were cut and stained for either p53 (CM5, Novocastra) or pan-keratin (AE1/AE3, Novocastra) using high-temperature antigen retrieval in 10 mM citrate buffer (pH 6), or for BrdU (Dako, Glostrup, Denmark) after treating with 2N HCl followed by 0.1% trypsin. After staining with the primary antibody, the sections were stained with a biotin-conjugated secondary (Vector Laboratories, Burlingame, California, United States) followed by StreptABComplex/HRP (Dako). Slides were developed with DAB/NiCl and counterstained with methyl green. Control sections with no primary antibody were run concurrently. Other sections were cut and stained using a standard H&E method. Proliferation index was determined by counting the number of BrdU-stained cells per 40x field. The apoptotic index was determined by counting the H&E slides for the number of apoptotic figures per 40x field. All counts were done on a Nikon (Tokyo, Japan) Labophot-2 microscope.
###end p 54
###begin title 55
Semiquantitative PCR analysis
###end title 55
###begin p 56
###xml 118 121 118 121 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 115 121 115 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>Arf</sup></italic>
###xml 145 149 145 149 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf+</sup>
###xml 142 149 142 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>Arf+</sup></italic>
###xml 149 151 149 151 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">/&#8722;</sup>
###xml 295 302 295 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(Arf1),</italic>
###xml 331 338 331 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(Arf2),</italic>
###xml 371 377 371 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(ArfN)</italic>
###xml 409 414 409 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(Arf1</italic>
###xml 419 424 419 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf2)</italic>
###xml 446 451 446 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(Arf2</italic>
###xml 456 461 456 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ArfN)</italic>
###xml 690 693 684 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 693 696 687 690 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 756 779 750 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Timme1">Timme and Thompson 1994</xref>
###xml 883 886 877 880 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 880 886 874 880 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>Arf</sup></italic>
###xml 891 894 885 888 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
Genomic DNA was prepared from tumor tissue or normal kidney by QIAamp DNA Mini Kit (Qiagen). To measure LOH of the p19Arf wild-type allele in p19Arf+/- tumors, wild-type and knockout alleles were amplified by PCR separately then combined for electrophoresis. Primers 5'-AGTACAGCAGCGGGAGCATGG-3' (Arf1), 5'-TTGAGGAGGACCGTGAAGCCG-3' (Arf2), and 5'-ACCACACTGCTCGACATTGGG-3' (ArfN) were used to amplify wild-type (Arf1 and Arf2) and knockout alleles (Arf2 and ArfN) from 100 ng of genomic DNA using 68 degreesC for annealing and extension at 90 s for 30 cycles. Equal amounts of each PCR product were then combined for electrophoresis on a 2% TAE agarose gel. Wild-type and knockout alleles of p53+/- tumors were amplified in a separate reaction as described (Timme and Thompson 1994) for 30 cycles. PCR products were electrophoresed on a 2% TAE agarose gel. Comparison gradients for p19Arf and p53 were established by combining wild-type and knockout genomic DNA in quantified ratios, then amplifying as described above.
###end p 56
###begin title 57
Statistical methods
###end title 57
###begin p 58
###xml 36 39 36 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 33 39 33 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>Arf</sup></italic>
###xml 47 50 47 50 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 44 55 44 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>Arf</sup> /p53</italic>
###xml 215 235 215 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Zeger1">Zeger and Liang 1986</xref>
###xml 1374 1396 1374 1396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020242-Clayton1">Clayton and Hills 2003</xref>
###xml 1511 1514 1511 1514 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 1508 1514 1508 1514 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>Arf</sup></italic>
###xml 1522 1525 1522 1525 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 1519 1530 1519 1530 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>Arf</sup> /p53</italic>
###xml 373 378 <span type="species:ncbi:10090">mouse</span>
###xml 447 452 <span type="species:ncbi:10090">mouse</span>
###xml 756 760 <span type="species:ncbi:10090">mice</span>
In order to assess the impact of p19Arf (or p19Arf /p53) genotypes on the development of papillomas, longitudinal profiles of papilloma counts were analyzed using the generalized estimating equation (GEE) approach (Zeger and Liang 1986). GEE is an established statistical approach to the regression analysis of longitudinal data. Our analysis used papilloma counts of each mouse measured every 2 wk as the outcome variable and incorporated within-mouse correlations of papilloma counts over time in making statistical inference. Using GEE, we estimated average differences of papilloma counts across genotypes after DMBA administration. Since the development of papillomas depends on the time since the DMBA administration and may differ by the sex of the mice, the effects of the weeks since the DMBA administration and sex were controlled for in the GEE analysis as covariates. A working correlation structure of the GEE analysis was specified as the first-order autoregressive structure over the time since the DMBA administration; however, GEE is robust against the misspecification of the correlation structure. In contrast to papillomas, the overall number of carcinomas developed during the experiment was relatively small. Thus, we analyzed differences by genotype in the probability of developing a carcinoma after DMBA administration. A logistic regression model (Clayton and Hills 2003) was used to assess the odds of developing a carcinoma during the experimental period and to compare it across p19Arf (or p19Arf /p53) genotypes. Estimates of relative odds were adjusted for sex effects. Fisher's exact test was used for comparing two proportions such as comparing LOH proportions between papillomas and carcinomas. All statistical tests were two-sided.
###end p 58
###begin p 59
###xml 126 129 126 129 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 139 143 <span type="species:ncbi:10090">mice</span>
We thank S. Lawrence Bailey for excellent technical assistance, Martine Roussel and Charles Sherr for generously providing p19Arf knockout mice, and Denny Liggett for assistance with histopathological evaluation of tumor samples. We also thank numerous colleagues at the Fred Hutchinson Cancer Research Center for critical reading of the manuscript. This work was supported by a National Institutes of Health T32 CA8046 Interdisciplinary Training Grant in Cancer Research to KSK-S and NCI R01 (CA099517) and NIEHS U01 (ES11045) grants to CJK.
###end p 59
###begin title 60
References
###end title 60
###begin article-title 61
Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways
###end article-title 61
###begin article-title 62
Molecular mechanisms leading to cell junction (cadherin) deficiency in invasive carcinomas
###end article-title 62
###begin article-title 63
###xml 17 22 <span type="species:ncbi:9606">human</span>
ras oncogenes in human cancer: A review
###end article-title 63
###begin article-title 64
###xml 124 129 <span type="species:ncbi:10090">mouse</span>
Genetic changes in skin tumour progression: Correlation between presence of a mutant ras gene and loss of heterozygosity on mouse chromosome 7
###end article-title 64
###begin article-title 65
###xml 65 70 <span type="species:ncbi:10090">mouse</span>
Progression of squamous carcinoma cells to spindle carcinomas of mouse skin is associated with an imbalance of H-ras alleles on chromosome 7
###end article-title 65
###begin article-title 66
###xml 105 109 <span type="species:ncbi:10090">mice</span>
Loss of heterozygosity and mutational alterations of the p53 gene in skin tumors of interspecific hybrid mice
###end article-title 66
###begin article-title 67
Increasing complexity of Ras signaling
###end article-title 67
###begin article-title 68
###xml 160 164 <span type="species:ncbi:10090">mice</span>
Expression pattern of the cell adhesion molecules. E-cadherin, P-cadherin and alpha 6 beta 4 intergrin is altered in pre-malignant skin tumors of p53-deficient mice
###end article-title 68
###begin article-title 69
###xml 93 98 <span type="species:ncbi:10090">mouse</span>
A critical role for ras-mediated, epidermal growth factor receptor-dependent angiogenesis in mouse skin carcinogenesis
###end article-title 69
###begin article-title 70
Statistical models in epidemiology
###end article-title 70
###begin article-title 71
###xml 54 59 <span type="species:ncbi:9606">human</span>
NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia
###end article-title 71
###begin article-title 72
E1A signaling to p53 involves the p19(ARF) tumor suppressor
###end article-title 72
###begin article-title 73
###xml 29 34 <span type="species:ncbi:10090">mouse</span>
Multistage carcinogenesis in mouse skin
###end article-title 73
###begin article-title 74
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
###end article-title 74
###begin article-title 75
Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis
###end article-title 75
###begin article-title 76
Oncogenic ras and p53 cooperate to induce cellular senescence
###end article-title 76
###begin article-title 77
Predisposition to neoplastic transformation caused by gene replacement of H-ras1
###end article-title 77
###begin article-title 78
The complexity of p53 modulation: Emerging patterns from divergent signals
###end article-title 78
###begin article-title 79
###xml 51 66 <span type="species:ncbi:10090">transgenic mice</span>
###xml 117 122 <span type="species:ncbi:9606">human</span>
Paradoxical tumor inhibitory effect of p53 loss in transgenic mice expressing epidermal-targeted v-ras/Ha, v-fos, or human transforming growth factor alpha
###end article-title 79
###begin article-title 80
The hallmarks of cancer
###end article-title 80
###begin article-title 81
Mdm2 promotes the rapid degradation of p53
###end article-title 81
###begin article-title 82
Mediation of c-Myc-induced apoptosis by p53
###end article-title 82
###begin article-title 83
Amplification of wild-type K-ras promotes growth of head and neck squamous cell carcinoma
###end article-title 83
###begin article-title 84
###xml 42 47 <span type="species:ncbi:9606">human</span>
Database of p53 gene somatic mutations in human tumors and cell lines
###end article-title 84
###begin article-title 85
Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53
###end article-title 85
###begin article-title 86
###xml 8 13 <span type="species:ncbi:10090">mouse</span>
AP-1 in mouse development and tumorigenesis
###end article-title 86
###begin article-title 87
###xml 25 30 <span type="species:ncbi:10090">mouse</span>
Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19/ARF
###end article-title 87
###begin article-title 88
###xml 32 36 <span type="species:ncbi:10090">mice</span>
Tumor spectrum in ARF-deficient mice
###end article-title 88
###begin article-title 89
Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors
###end article-title 89
###begin article-title 90
p53 induction and apoptosis in response to radio- and chemotherapy in vivo is tumor-type-dependent
###end article-title 90
###begin article-title 91
###xml 97 102 <span type="species:ncbi:9606">human</span>
p38 kinase is a key signaling molecule for H-Ras-induced cell motility and invasive phenotype in human breast epithelial cells
###end article-title 91
###begin article-title 92
p53: Puzzle and paradigm
###end article-title 92
###begin article-title 93
Regulation of p53 stability by Mdm2
###end article-title 93
###begin article-title 94
Arf induces p53-dependent and-independent antiproliferative genes
###end article-title 94
###begin article-title 95
###xml 47 52 <span type="species:ncbi:9606">human</span>
CDK4 coexpression with Ras generates malignant human epidermal tumorigenesis
###end article-title 95
###begin article-title 96
Oncogenic ras activates the ARF-p53 pathway to suppress epithelial cell transformation
###end article-title 96
###begin article-title 97
Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis
###end article-title 97
###begin article-title 98
Tumor suppression by Ink4a-Arf: Progress and puzzles
###end article-title 98
###begin article-title 99
###xml 74 79 <span type="species:ncbi:10090">mouse</span>
The Arf tumor suppressor gene promotes hyaloid vascular regression during mouse eye development
###end article-title 99
###begin article-title 100
###xml 42 48 <span type="species:ncbi:10090">murine</span>
Cooperativity of p19ARF, Mdm2, and p53 in murine tumorigenesis
###end article-title 100
###begin article-title 101
TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells
###end article-title 101
###begin article-title 102
Metastasis is driven by sequential elevation of H-ras and Smad2 levels
###end article-title 102
###begin article-title 103
Transcriptional regulation of cell invasion: AP-1 regulation of a multigenic invasion programme
###end article-title 103
###begin article-title 104
p19ARF links the tumour suppressor p53 to Ras
###end article-title 104
###begin article-title 105
A causal role for E-cadherin in the transition from adenoma to carcinoma
###end article-title 105
###begin article-title 106
The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53
###end article-title 106
###begin article-title 107
###xml 8 11 <span type="species:ncbi:10116">rat</span>
Primary rat embryo cells transformed by one or two oncogenes show different metastatic potentials
###end article-title 107
###begin article-title 108
Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest
###end article-title 108
###begin article-title 109
###xml 64 69 <span type="species:ncbi:10090">mouse</span>
Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis
###end article-title 109
###begin article-title 110
p53- and Mdm2-independent repression of NF-kappa B transactivation by the ARF tumor suppressor
###end article-title 110
###begin article-title 111
###xml 119 147 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein
###end article-title 111
###begin article-title 112
The p16INK4a/CDKN2A tumor suppressor and its relatives
###end article-title 112
###begin article-title 113
###xml 52 57 <span type="species:ncbi:10090">mouse</span>
Alterations of the p53 tumor suppressor gene during mouse skin tumor progression
###end article-title 113
###begin article-title 114
c-fos is required for malignant progression of skin tumors
###end article-title 114
###begin article-title 115
INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53
###end article-title 115
###begin article-title 116
Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells
###end article-title 116
###begin article-title 117
###xml 107 112 <span type="species:ncbi:10090">mouse</span>
A cellular oncogene (c-Ki-ras) is amplified, overexpressed, and located within karyotypic abnormalities in mouse adrenocortical tumour cells
###end article-title 117
###begin article-title 118
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
###end article-title 118
###begin article-title 119
Cellular senescence: Mitotic clock or culture shock?
###end article-title 119
###begin article-title 120
The ARF/p53 pathway
###end article-title 120
###begin article-title 121
Understanding Ras: 'It ain't over 'til it's over'
###end article-title 121
###begin article-title 122
The cellular response to p53: The decision between life and death
###end article-title 122
###begin article-title 123
The relevance of oncogenes as prognostic markers in cervical cancer
###end article-title 123
###begin article-title 124
###xml 33 38 <span type="species:ncbi:9606">human</span>
The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2
###end article-title 124
###begin article-title 125
Nucleolar Arf tumor suppressor inhibits ribosomal RNA processing
###end article-title 125
###begin article-title 126
###xml 38 43 <span type="species:ncbi:9606">human</span>
Expression of p21 ras oncoproteins in human cancers
###end article-title 126
###begin article-title 127
Nucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2-mediated degradation of p53
###end article-title 127
###begin article-title 128
###xml 42 46 <span type="species:ncbi:10090">mice</span>
Rapid allelotype analysis of p53 knockout mice
###end article-title 128
###begin article-title 129
Activated ras regulates the proliferation/apoptosis balance and early survival of developing micrometastases
###end article-title 129
###begin article-title 130
Cancer: A deadly inheritance
###end article-title 130
###begin article-title 131
Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression
###end article-title 131
###begin article-title 132
Live or let die: The cell's response to p53
###end article-title 132
###begin article-title 133
Signaling pathways in Ras-mediated tumorigenicity and metastasis
###end article-title 133
###begin article-title 134
Nucleolar Arf sequesters Mdm2 and activates p53
###end article-title 134
###begin article-title 135
p53-independent functions of the p19(ARF) tumor suppressor
###end article-title 135
###begin article-title 136
###xml 59 62 <span type="species:ncbi:10116">rat</span>
###xml 111 116 <span type="species:ncbi:9606">human</span>
Oncogene amplification during tumorigenesis of established rat fibroblasts reversibly transformed by activated human ras oncogenes
###end article-title 136
###begin article-title 137
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human tumor suppressor ARF impedes S-phase progression independent of p53
###end article-title 137
###begin article-title 138
Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles
###end article-title 138
###begin article-title 139
Alterations of myc, myb, and rasHa proto-oncogenes in cancers are frequent and show clinical correlation
###end article-title 139
###begin article-title 140
Promising molecular targets for cancer prevention: AP-1, NF-kappa B and Pdcd4
###end article-title 140
###begin article-title 141
The pathogenesis of squamous cell cancer: Lessons learned from studies of skin carcinogenesis-Thirty-third G. H. A. Clowes Memorial Award Lecture
###end article-title 141
###begin article-title 142
Longitudinal data analysis for discrete and continuous outcomes
###end article-title 142
###begin article-title 143
###xml 13 18 <span type="species:ncbi:9606">human</span>
Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53
###end article-title 143
###begin article-title 144
Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization
###end article-title 144
###begin article-title 145
Rho family proteins and Ras transformation: The RHOad less traveled gets congested
###end article-title 145
###begin article-title 146
Oncogenic Ras downregulates Rac activity, which leads to increased Rho activity and epithelial-mesenchymal transition
###end article-title 146
###begin article-title 147
A genome-wide survey of RAS transformation targets
###end article-title 147
###begin title 148
Abbreviations
###end title 148
###begin p 149
###xml 3 6 3 6 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
p19Arf
###end p 149
###begin p 150
generalized estimating equation
###end p 150
###begin p 151
hematoxylin/eosin
###end p 151
###begin p 152
loss of heterozygosity
###end p 152
###begin p 153
squamous cell carcinoma
###end p 153
###begin title 154
Figures and Tables
###end title 154
###begin title 155
###xml 53 57 53 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf</sup>
###xml 50 57 50 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf</sup></italic>
###xml 68 72 <span type="species:ncbi:10090">Mice</span>
Skin Tumor Multiplicity, Size, and Progression in p19 Arf-Deficient Mice
###end title 155
###begin p 156
###xml 134 138 134 138 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf</sup>
###xml 144 147 144 147 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 131 147 131 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf</sup> (Arf)<sup>+/&#8722;</sup></italic>
###xml 155 162 155 162 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf&#8722;/&#8722;</sup>
###xml 152 162 152 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf&#8722;/&#8722;</sup></italic>
###xml 207 214 207 214 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf+/+</sup>
###xml 204 214 204 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf+/+</sup></italic>
###xml 66 71 <span type="species:ncbi:10090">mouse</span>
###xml 163 167 <span type="species:ncbi:10090">mice</span>
###xml 215 219 <span type="species:ncbi:10090">mice</span>
(A) Average number of papillomas (more than 2 mm in diameter) per mouse is plotted versus the number of weeks postinitiation. Both p19 Arf (Arf)+/- and p19 Arf-/- mice show greater numbers of tumors than p19 Arf+/+ mice.
###end p 156
###begin p 157
###xml 52 59 52 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf+/+</sup>
###xml 64 71 64 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf+/&#8722;</sup>
###xml 49 72 49 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf+/+</sup>, p19<sup>&#8202;Arf+/&#8722;</sup>,</italic>
###xml 80 87 80 87 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf&#8722;/&#8722;</sup>
###xml 77 87 77 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf&#8722;/&#8722;</sup></italic>
###xml 185 192 185 192 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf+/&#8722;</sup>
###xml 182 192 182 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf+/&#8722;</sup></italic>
###xml 200 207 200 207 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf&#8722;/&#8722;</sup>
###xml 197 207 197 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf&#8722;/&#8722;</sup></italic>
###xml 224 231 224 231 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf+/+</sup>
###xml 221 231 221 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf+/+</sup></italic>
###xml 236 237 236 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">.</italic>
###xml 88 92 <span type="species:ncbi:10090">mice</span>
###xml 208 212 <span type="species:ncbi:10090">mice</span>
###xml 232 236 <span type="species:ncbi:10090">mice</span>
(B) Comparison of papilloma size (in mm) between p19 Arf+/+, p19 Arf+/-, and p19 Arf-/- mice through 28 wk postinitiation. An increase in the largest size class of tumors is seen in p19 Arf+/- and p19 Arf-/- mice but not p19 Arf+/+ mice.
###end p 157
###begin p 158
###xml 111 118 111 118 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf&#8722;/&#8722;</sup>
###xml 106 118 106 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">.&#8202;p19<sup>&#8202;Arf&#8722;/&#8722;</sup></italic>
###xml 206 213 206 213 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf+/&#8722;</sup>
###xml 203 213 203 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf+/&#8722;</sup></italic>
###xml 255 262 255 262 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf&#8722;/&#8722;</sup>
###xml 252 262 252 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf&#8722;/&#8722;</sup></italic>
###xml 270 277 270 277 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf+/+</sup>
###xml 267 277 267 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf+/+</sup></italic>
###xml 459 463 459 463 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf</sup>
###xml 456 463 456 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf</sup></italic>
###xml 18 22 <span type="species:ncbi:10090">mice</span>
###xml 119 123 <span type="species:ncbi:10090">mice</span>
###xml 214 218 <span type="species:ncbi:10090">mice</span>
###xml 278 282 <span type="species:ncbi:10090">mice</span>
###xml 381 386 <span type="species:ncbi:10090">mouse</span>
###xml 474 478 <span type="species:ncbi:10090">mice</span>
###xml 497 501 <span type="species:ncbi:10090">mice</span>
(C) Percentage of mice bearing at least one carcinoma is plotted versus the number of weeks postinitiation. p19 Arf-/- mice show the shortest latency and greatest incidence of carcinoma conversion, with p19 Arf+/- mice showing an incidence between the p19 Arf-/- and p19 Arf+/+ mice. Time of appearance of lymph node metastasis is noted above the graph as a vertical line for each mouse analyzed. Metastasis to lymph node occurred frequently and sooner in p19 Arf-deficient mice than in wild-type mice.
###end p 158
###begin title 159
###xml 57 61 57 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf</sup>
###xml 54 61 54 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf</sup></italic>
###xml 72 76 <span type="species:ncbi:10090">Mice</span>
Metastasis of Primary SCC to Lymph Nodes and Lungs in p19 Arf-Deficient Mice
###end title 159
###begin p 160
###xml 41 46 <span type="species:ncbi:10090">mouse</span>
(A) Underside of skin from tumor-bearing mouse shows newly formed blood vessels surrounding tumor site (arrow) and leading to inguinal lymph node (arrowhead).
###end p 160
###begin p 161
(B) Enlarged inquinal lymph node (left) containing metastatic SCC and blood vessel formation (arrow) compared to normal lymph node (right).
###end p 161
###begin p 162
(C) H&E stain of carcinoma section with prominent blood vessel (bv). Carcinoma cells (ca) have penetrated blood vessel wall (arrow).
###end p 162
###begin p 163
(D) H&E stain of lymph node bearing infiltrating SCC cells (arrow) among normal lymphocytes (arrowhead).
###end p 163
###begin p 164
(E) H&E stain of lymph node bearing metastatic differentiated SCC.
###end p 164
###begin p 165
(F) Immunostain with pan-keratin antibody of papilloma.
###end p 165
###begin p 166
(G) Immunostain with pan-keratin antibody of lymph node with metastatic SCC.
###end p 166
###begin p 167
(H and I) H&E stain of normal lung (arrowhead) with large metastatic SCC deposit (arrow).
###end p 167
###begin p 168
(J) H&E stain of lung metastasis with secondary site of infiltration (arrow).
###end p 168
###begin p 169
(D-G, J): 20x magnification. Inserts in (E-G): 40x magnification.
###end p 169
###begin title 170
###xml 46 49 46 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 43 49 43 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>Arf</sup></italic>
###xml 60 64 <span type="species:ncbi:10090">Mice</span>
Reduced p53 Expression in Skin Tumors from p19Arf-Deficient Mice
###end title 170
###begin p 171
###xml 70 74 70 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf</sup>
###xml 80 83 80 83 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 88 95 88 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf+/&#8722;</sup>
###xml 67 96 67 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf</sup> (Arf)<sup>+/+</sup>, p19<sup>&#8202;Arf+/&#8722;</sup>,</italic>
###xml 104 111 104 111 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf&#8722;/&#8722;</sup>
###xml 101 111 101 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf&#8722;/&#8722;</sup></italic>
###xml 112 116 <span type="species:ncbi:10090">mice</span>
(A) Western blot analysis of nuclear lysates from skin tumors from p19 Arf (Arf)+/+, p19 Arf+/-, and p19 Arf-/- mice using p53-specific antibody. PA, papilloma; skin IR, irradiated normal skin
###end p 171
###begin p 172
###xml 69 76 69 76 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf+/+</sup>
###xml 81 88 81 88 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf+/&#8722;</sup>
###xml 66 89 66 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf+/+</sup>, p19<sup>&#8202;Arf+/&#8722;</sup>,</italic>
###xml 97 104 97 104 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf&#8722;/&#8722;</sup>
###xml 94 104 94 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf&#8722;/&#8722;</sup></italic>
###xml 212 219 212 219 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf+/+</sup>
###xml 209 219 209 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf+/+</sup></italic>
###xml 227 234 227 234 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf&#8722;/&#8722;</sup>
###xml 224 234 224 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf&#8722;/&#8722;</sup></italic>
###xml 303 310 303 310 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf&#8722;/&#8722;</sup>
###xml 300 310 300 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf&#8722;/&#8722;</sup></italic>
###xml 386 393 386 393 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf&#8722;/&#8722;</sup>
###xml 383 393 383 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf&#8722;/&#8722;</sup></italic>
###xml 105 109 <span type="species:ncbi:10090">mice</span>
###xml 235 239 <span type="species:ncbi:10090">mice</span>
###xml 311 315 <span type="species:ncbi:10090">mice</span>
###xml 394 398 <span type="species:ncbi:10090">mice</span>
(B) p53 immunostain of paraffin-embedded skin tumor sections from p19 Arf+/+, p19 Arf+/-, and p19 Arf-/- mice (arrows indicate positive stained cells) (top). p53 immunostain of irradiated papillomas (IR) from p19 Arf+/+ and p19 Arf-/- mice (bottom). p53 is not detected in normal skin or tumors from p19 Arf-/- mice, but is induced by irradiation in both normal and tumor cells from p19 Arf-/- mice.
###end p 172
###begin title 173
###xml 20 23 20 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 17 23 17 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>Arf</sup></italic>
###xml 37 43 37 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf+/&#8722;</sup>
###xml 34 43 34 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>Arf+/&#8722;</sup></italic>
LOH of Wild-Type p19Arf Allele in p19Arf+/- Tumors
###end title 173
###begin p 174
###xml 61 64 61 64 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 58 64 58 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>Arf</sup></italic>
###xml 78 84 78 84 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf+/&#8722;</sup>
###xml 75 84 75 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>Arf+/&#8722;</sup></italic>
###xml 267 270 267 270 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 264 270 264 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>Arf</sup></italic>
(A) LOH analysis by semiquantitative PCR of the wild-type p19Arf allele in p19Arf+/- papillomas and carcinomas. Gradient made from kidney DNA used for quantitation of wt/mu ratio (top row). wt, wild-type allele; mu, knockout allele; asterisk, loss or reduction of p19Arf wild-type band.
###end p 174
###begin p 175
###xml 94 100 94 100 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf+/+</sup>
###xml 105 111 105 111 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf+/&#8722;</sup>
###xml 91 112 91 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>Arf+/+</sup>, p19<sup>Arf+/&#8722;</sup>,</italic>
###xml 120 126 120 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf&#8722;/&#8722;</sup>
###xml 117 126 117 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>Arf&#8722;/&#8722;</sup></italic>
###xml 127 131 <span type="species:ncbi:10090">mice</span>
(B) Western blot analysis of nuclear lysates from papillomas (PA) and carcinomas (CA) from p19Arf+/+, p19Arf+/-, and p19Arf-/- mice.
###end p 175
###begin title 176
###xml 49 53 49 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf</sup>
###xml 46 58 46 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf</sup> /p53</italic>
###xml 75 79 <span type="species:ncbi:10090">Mice</span>
Tumor Multiplicity and Proliferative Index in p19 Arf /p53 Compound Mutant Mice
###end title 176
###begin p 177
###xml 66 71 <span type="species:ncbi:10090">mouse</span>
(A) Average number of papillomas (more than 2 mm in diameter) per mouse is plotted against the number of weeks post-initiation.
###end p 177
###begin p 178
###xml 27 31 27 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf</sup>
###xml 37 40 37 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 45 48 45 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 24 49 24 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf</sup> (Arf)<sup>&#8722;/&#8722;</sup>, p53<sup>&#8722;/&#8722;</sup>,</italic>
###xml 57 63 57 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf&#8722;/&#8722;</sup>
###xml 66 69 66 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 54 69 54 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>Arf&#8722;/&#8722;</sup>p53<sup>&#8722;/&#8722;</sup></italic>
###xml 172 176 172 176 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf</sup>
###xml 169 176 169 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf</sup></italic>
###xml 250 253 250 253 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 247 258 247 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>Arf</sup> /p53</italic>
###xml 292 295 292 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 70 74 <span type="species:ncbi:10090">mice</span>
###xml 124 128 <span type="species:ncbi:10090">mice</span>
###xml 196 200 <span type="species:ncbi:10090">mice</span>
###xml 275 279 <span type="species:ncbi:10090">mice</span>
(B) Image of wild-type, p19 Arf (Arf)-/-, p53-/-, and p19Arf-/-p53-/- mice with skin tumors at time of sacrifice. Wild-type mice show large exophytic tumors, while both p19 Arf- and p53-deficient mice have endophytic tumors. Note larger tumors in p19Arf /p53 compound mutant mice relative to p53 single mutants.
###end p 178
###begin p 179
###xml 57 60 57 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 65 72 65 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf&#8722;/&#8722;</sup>
###xml 52 73 52 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">, p53<sup>&#8722;/&#8722;</sup>, p19<sup>&#8202;Arf&#8722;/&#8722;</sup>,</italic>
###xml 81 88 81 88 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf&#8722;/&#8722;</sup>
###xml 91 94 91 94 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 78 94 78 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf&#8722;/&#8722;</sup>p53<sup>&#8722;/&#8722;</sup></italic>
###xml 214 217 212 215 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 211 217 209 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>&#8722;/&#8722;</sup></italic>
###xml 285 292 283 290 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf&#8722;/&#8722;</sup>
###xml 282 292 280 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf&#8722;/&#8722;</sup></italic>
###xml 314 315 312 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 95 99 <span type="species:ncbi:10090">mice</span>
###xml 204 208 <span type="species:ncbi:10090">mice</span>
(C) BrdU-positive cells in papillomas from wild-type, p53-/-, p19 Arf-/-, and p19 Arf-/-p53-/- mice at 10 wk postinitiation. (Bars represent average counts +/- standard deviation from ten fields and five mice). p53-/- tumors show significantly fewer BrdU-positive cells than either p19 Arf-/- or wild-type tumors (p < 0.05, Wilcoxon one-sided t-test).
###end p 179
###begin title 180
###xml 22 25 22 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 36 39 36 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 33 44 33 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>Arf</sup> /p53</italic>
###xml 61 65 <span type="species:ncbi:10090">Mice</span>
Tumor Progression and p53 LOH in p19Arf /p53 Compound Mutant Mice
###end title 180
###begin p 181
###xml 142 146 142 146 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf</sup>
###xml 139 153 139 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf</sup> (Arf)-</italic>
###xml 158 161 158 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 215 216 215 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">.</italic>
###xml 280 287 280 287 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf&#8722;/&#8722;</sup>
###xml 277 287 277 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf&#8722;/&#8722;</sup></italic>
###xml 307 310 307 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 324 327 324 327 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 332 335 332 335 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 321 336 321 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>+/+</sup>, p53<sup>+/&#8722;</sup>,</italic>
###xml 343 346 343 346 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 340 346 340 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>&#8722;/&#8722;</sup></italic>
###xml 37 42 <span type="species:ncbi:10090">mouse</span>
###xml 288 292 <span type="species:ncbi:10090">mice</span>
(A) Average number of carcinomas per mouse is plotted against the number of weeks postinitiation. Tumor progression was accelerated in all p19 Arf (Arf)- and p53-deficient genotypes compared to wild-type littermates. Carcinoma latency and multiplicity was almost identical for p19 Arf-/- mice regardless of p53 genotype (p53+/+, p53+/-, or p53-/-).
###end p 181
###begin p 182
###xml 25 28 25 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 66 70 66 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf</sup>
###xml 63 75 63 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf</sup> /p53</italic>
###xml 259 263 259 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53.</italic>
(B) LOH of the wild-type p53 allele by semiquantitative PCR in p19 Arf /p53 compound tumors. Gradient made from kidney DNA used for quantitation of wt/mu ratio (top row). wt, wild-type allele; mu, knockout allele; asterisk, tumors with reduction of wild-type p53.
###end p 182
###begin title 183
An Integrated Model of SCC Progression
###end title 183
###begin p 184
###xml 77 81 77 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hras</italic>
###xml 233 237 233 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hras</italic>
###xml 306 309 306 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ras</italic>
###xml 389 393 389 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53,</italic>
###xml 416 419 416 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ras</italic>
###xml 576 579 576 579 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 619 622 619 622 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 703 706 703 706 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 806 809 806 809 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 860 864 860 864 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;Arf</sup>
###xml 857 864 857 864 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>&#8202;Arf</sup></italic>
###xml 868 871 868 871 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 911 914 911 914 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ras</italic>
###xml 35 40 <span type="species:ncbi:10090">mouse</span>
At the genetic level, treatment of mouse skin with DMBA induces mutations in Hras resulting in initiated cells that express constitutively active Ras protein (grey rectangles). TPA treatment is required for clonal expansion of these Hras mutant cells to form papillomas. Frequent duplication of the mutant Ras allele in papillomas indicates increased Ras signaling is favored. Mutation of p53, as well as additional Ras gene amplification, is seen in carcinomas, particularly in the most aggressive tumors (black rectangles). At the signaling level, mutant Ras upregulates p19Arf (Arf), which in turn activates p53. p19Arf, in turn, inhibits growth of Hras-driven tumors in a p53-independent manner. p19Arf, acting through p53, also inhibits malignant progression and metastasis. As Ras signals through p19Arf and p53, selection for subsequent mutations in p19 Arf or p53 is a direct consequence of the initial Ras mutation. In this model, Ras drives tumor progression through direct signaling effects and by dictating the evolution pathway of the tumor.
###end p 184
###begin title 185
Metastatic Frequency of SCC
###end title 185
###begin p 186
Denominator indicates number of tissues examined. Numerator indicates number of tissues bearing SCC
###end p 186
###begin p 187
###xml 0 22 0 22 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflicts of interest.</bold>
Conflicts of interest. The authors have declared that no conflicts of interest exist.
###end p 187
###begin p 188
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Author contributions.</bold>
Author contributions. KSK-S and CJK conceived and designed the experiments. KSK-S and KEG performed the experiments. KSK-S, YY, and CJK analyzed the data. KSK-S and KEG contributed reagents/materials/analysis tools. KSK-S and CJK wrote the paper.
###end p 188
###begin p 189
Academic Editor: Nicholas Hastie, Western General Hospital
###end p 189
###begin p 190
###xml 65 68 65 68 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
Citation: Kelly-Spratt KS, Gurley KE, Yasui Y, Kemp CJ (2004) p19Arf suppresses growth, progression, and metastasis of Hras-driven carcinomas through p53-dependent and -independent pathways. PLoS Biol 2(8): e242.
###end p 190

